Document And Entity Information
Document And Entity Information | 6 Months Ended |
Jun. 30, 2024 | |
Document Information Line Items | |
Entity Registrant Name | BOLT PROJECTS HOLDINGS, INC. |
Document Type | S-1 |
Amendment Flag | false |
Entity Central Index Key | 0001841125 |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Incorporation, State or Country Code | DE |
Consolidated Condensed Balance
Consolidated Condensed Balance Sheets - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 |
Current Assets | |||
Cash | $ 28,657 | $ 306,034 | $ 348,749 |
Prepaid expenses | 140,308 | 152,663 | 72,297 |
Total Current Assets | 168,965 | 458,697 | 421,046 |
Cash held in Trust Account | 6,365,874 | 6,218,429 | 290,646,467 |
Total Assets | 6,534,839 | 6,677,126 | 291,067,513 |
Current Liabilities | |||
Accounts payable and accrued expenses | 1,556,739 | 1,135,140 | 249,489 |
Excise tax payable | 2,870,720 | 2,870,720 | |
Income taxes payable | 6,323 | 453,342 | 248,647 |
Total Current Liabilities | 7,128,877 | 6,522,217 | 586,986 |
Deferred underwriting fee payable | 10,062,500 | 10,062,500 | 10,062,500 |
Warrant liabilities | 2,187,500 | 2,041,667 | 145,833 |
Total Liabilities | 19,378,877 | 18,626,384 | 10,795,319 |
Commitments and Contingencies | |||
Class A common stock subject to possible redemption | 6,357,464 | 6,228,145 | 290,357,770 |
Stockholders’ Deficit | |||
Preferred stock value | |||
Additional paid-in capital | |||
Accumulated deficit | (19,202,221) | (18,178,122) | (10,086,295) |
Total Stockholders’ Deficit | (19,201,502) | (18,177,403) | (10,085,576) |
TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ DEFICIT | 6,534,839 | 6,677,126 | 291,067,513 |
Related Party | |||
Current Liabilities | |||
Promissory note – related party | 648,041 | 578,689 | |
Convertible notes - related party | 2,047,054 | 1,484,326 | 88,850 |
Class A Common Stock | |||
Current Liabilities | |||
Class A common stock subject to possible redemption | 6,357,464 | 6,228,145 | 290,357,770 |
Stockholders’ Deficit | |||
Common stock value | 705 | 705 | |
Class B Common Stock | |||
Stockholders’ Deficit | |||
Common stock value | $ 14 | $ 14 | $ 719 |
Consolidated Condensed Balanc_2
Consolidated Condensed Balance Sheets (Parentheticals) - $ / shares | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | |||
Preferred stock, shares outstanding | |||
Class A Common Stock | |||
Common stock subject to possible redemption, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Common stock subject to possible redemption, shares authorized | 200,000,000 | 200,000,000 | 200,000,000 |
Common stock subject to possible redemption, shares at a redemption | 577,937 | 577,937 | 28,750,000 |
Common stock subject to possible redemption, per share (in Dollars per share) | $ 11 | $ 10.76 | $ 10.1 |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 | 200,000,000 |
Common stock, shares issued | 7,047,500 | 7,047,500 | |
Common stock, shares outstanding | 7,047,500 | 7,047,500 | |
Class B Common Stock | |||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 20,000,000 | 20,000,000 | 20,000,000 |
Common stock, shares issued | 140,000 | 140,000 | 7,187,500 |
Common stock, shares outstanding | 140,000 | 140,000 | 7,187,500 |
Unaudited Consolidated Condense
Unaudited Consolidated Condensed Statements of Operations - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Operational costs | $ 461,423 | $ 213,748 | $ 851,313 | $ 783,294 | $ 2,103,668 | $ 1,343,799 |
Loss from operations | (461,423) | (213,748) | (851,313) | (783,294) | (2,103,668) | (1,343,799) |
Other income (expense): | ||||||
Change in fair value of warrant liabilities | 729,167 | 291,666 | (145,833) | (291,667) | (1,895,834) | 7,138,542 |
Change in fair value of convertible notes | 811,150 | |||||
Interest income - bank | 9 | 4,081 | 1,596 | 4,492 | 8,240 | |
Interest earned on investments held in Trust Account | 59,337 | 196,773 | 118,093 | 2,771,356 | 3,176,694 | 4,000,465 |
Total other income (expense), net | 788,513 | 492,520 | (26,144) | 2,484,181 | 1,289,100 | 11,950,157 |
Income before provision for income taxes | 327,090 | 278,772 | (877,457) | 1,700,887 | (814,568) | 10,606,358 |
Provision for income taxes | (8,557) | (31,679) | (17,323) | (561,928) | (653,044) | (759,647) |
Net income (loss) | $ 318,533 | $ 247,093 | $ (894,780) | $ 1,138,959 | $ (1,467,612) | $ 9,846,711 |
Class A Common Stock Redeemable Shares | ||||||
Other income (expense): | ||||||
Basic weighted average shares outstanding (in Shares) | 577,937 | 2,100,481 | 577,937 | 2,100,481 | 7,511,529 | 28,750,000 |
Basic net (loss) income per share (in Dollars per share) | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | $ 0.27 |
Class A Common Stock Non-Redeemable Shares | ||||||
Other income (expense): | ||||||
Basic weighted average shares outstanding (in Shares) | 7,047,500 | 7,047,500 | 7,047,500 | 10,551,265 | 5,603,340 | 7,187,500 |
Basic net (loss) income per share (in Dollars per share) | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | $ 0.27 |
Class B Common Stock | ||||||
Other income (expense): | ||||||
Basic weighted average shares outstanding (in Shares) | 140,000 | 140,000 | 140,000 | 2,974,190 | 1,584,160 | 7,187,500 |
Basic net (loss) income per share (in Dollars per share) | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | $ 0.27 |
Unaudited Consolidated Conden_2
Unaudited Consolidated Condensed Statements of Operations (Parentheticals) - $ / shares | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Class A Common Stock Redeemable Shares | ||||||
Diluted weighted average shares outstanding | 577,937 | 2,100,481 | 577,937 | 2,100,481 | 7,511,529 | 28,750,000 |
Diluted net (loss) income per share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | $ 0.27 |
Class A Common Stock Non-Redeemable Shares | ||||||
Diluted weighted average shares outstanding | 7,047,500 | 7,047,500 | 7,047,500 | 10,551,265 | 5,603,340 | 7,187,500 |
Diluted net (loss) income per share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | $ 0.27 |
Class B Common Stock | ||||||
Diluted weighted average shares outstanding | 140,000 | 140,000 | 140,000 | 2,974,190 | 1,584,160 | 7,187,500 |
Diluted net (loss) income per share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | $ 0.27 |
Unaudited Consolidated Conden_3
Unaudited Consolidated Condensed Statements of Changes in Stockholders’ Deficit - USD ($) | Common Stock Class A | Common Stock Class B | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2021 | $ 719 | $ (17,075,236) | $ (17,074,517) | ||
Balance (in Shares) at Dec. 31, 2021 | 7,187,500 | ||||
Accretion for Class A common stock subject to redemption amount | (2,857,770) | (2,857,770) | |||
Net income (loss) | 9,846,711 | 9,846,711 | |||
Balance at Dec. 31, 2022 | $ 719 | (10,086,295) | (10,085,576) | ||
Balance (in Shares) at Dec. 31, 2022 | 7,187,500 | ||||
Accretion for Class A common stock subject to redemption amount | (1,994,334) | (1,994,334) | |||
Adjustment related to convertible promissory note | (811,150) | (811,150) | |||
Class B common stock converted to class A common stock | $ 705 | $ (705) | |||
Class B common stock converted to class A common stock (in Shares) | 7,047,500 | (7,047,500) | |||
Net income (loss) | 891,866 | 891,866 | |||
Balance at Mar. 31, 2023 | $ 705 | $ 14 | (11,999,913) | (11,999,194) | |
Balance (in Shares) at Mar. 31, 2023 | 7,047,500 | 140,000 | |||
Balance at Dec. 31, 2022 | $ 719 | (10,086,295) | (10,085,576) | ||
Balance (in Shares) at Dec. 31, 2022 | 7,187,500 | ||||
Net income (loss) | 1,138,959 | ||||
Balance at Jun. 30, 2023 | $ 705 | $ 14 | (12,119,975) | (12,119,256) | |
Balance (in Shares) at Jun. 30, 2023 | 7,047,500 | 140,000 | |||
Balance at Dec. 31, 2022 | $ 719 | (10,086,295) | (10,085,576) | ||
Balance (in Shares) at Dec. 31, 2022 | 7,187,500 | ||||
Accretion for Class A common stock subject to redemption amount | (2,942,345) | (2,942,345) | |||
Adjustment related to convertible promissory note | (811,150) | (811,150) | |||
Class B common stock converted to class A common stock | $ 705 | $ (705) | |||
Class B common stock converted to class A common stock (in Shares) | 7,047,500 | (7,047,500) | |||
Excise tax payable attributable to redemption of common stock | (2,870,720) | (2,870,720) | |||
Net income (loss) | (1,467,612) | (1,467,612) | |||
Balance at Dec. 31, 2023 | $ 705 | $ 14 | (18,178,122) | (18,177,403) | |
Balance (in Shares) at Dec. 31, 2023 | 7,047,500 | 140,000 | |||
Balance at Mar. 31, 2023 | $ 705 | $ 14 | (11,999,913) | (11,999,194) | |
Balance (in Shares) at Mar. 31, 2023 | 7,047,500 | 140,000 | |||
Accretion for Class A common stock subject to redemption amount | (367,155) | (367,155) | |||
Net income (loss) | 247,093 | 247,093 | |||
Balance at Jun. 30, 2023 | $ 705 | $ 14 | (12,119,975) | (12,119,256) | |
Balance (in Shares) at Jun. 30, 2023 | 7,047,500 | 140,000 | |||
Balance at Dec. 31, 2023 | $ 705 | $ 14 | (18,178,122) | (18,177,403) | |
Balance (in Shares) at Dec. 31, 2023 | 7,047,500 | 140,000 | |||
Accretion for Class A common stock subject to redemption amount | (43,863) | (43,863) | |||
Net income (loss) | (1,213,313) | (1,213,313) | |||
Balance at Mar. 31, 2024 | $ 705 | $ 14 | (19,435,298) | (19,434,579) | |
Balance (in Shares) at Mar. 31, 2024 | 7,047,500 | 140,000 | |||
Balance at Dec. 31, 2023 | $ 705 | $ 14 | (18,178,122) | (18,177,403) | |
Balance (in Shares) at Dec. 31, 2023 | 7,047,500 | 140,000 | |||
Net income (loss) | (894,780) | ||||
Balance at Jun. 30, 2024 | $ 705 | $ 14 | (19,202,221) | (19,201,502) | |
Balance (in Shares) at Jun. 30, 2024 | 7,047,500 | 140,000 | |||
Balance at Mar. 31, 2024 | $ 705 | $ 14 | (19,435,298) | (19,434,579) | |
Balance (in Shares) at Mar. 31, 2024 | 7,047,500 | 140,000 | |||
Accretion for Class A common stock subject to redemption amount | (85,456) | (85,456) | |||
Net income (loss) | 318,533 | 318,533 | |||
Balance at Jun. 30, 2024 | $ 705 | $ 14 | $ (19,202,221) | $ (19,201,502) | |
Balance (in Shares) at Jun. 30, 2024 | 7,047,500 | 140,000 |
Unaudited Consolidated Conden_4
Unaudited Consolidated Condensed Statements of Cash Flows - USD ($) | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Cash Flows from Operating Activities: | ||||
Net (loss) income | $ (894,780) | $ 1,138,959 | $ (1,467,612) | $ 9,846,711 |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||||
Change in fair value of convertible notes | (811,150) | |||
Change in fair value of warrant liabilities | 145,833 | 291,667 | 1,895,834 | (7,138,542) |
Interest earned on investments held in Trust Account | (118,093) | (2,771,356) | (3,176,694) | (4,000,465) |
Changes in operating assets and liabilities: | ||||
Prepaid expenses | 12,355 | (99,891) | (80,366) | 279,888 |
Accounts payable and accrued expenses | 421,599 | 59,400 | 885,650 | (72,585) |
Income taxes payable | (447,019) | 113,579 | 204,695 | 248,647 |
Net cash used in operating activities | (880,105) | (1,267,642) | (1,738,493) | (1,647,496) |
Cash Flows from Investing Activities: | ||||
Investment of cash into Trust Account | (69,352) | (252,060) | (578,694) | |
Cash withdrawn from Trust Account to pay franchise and income taxes | 40,000 | 983,538 | 1,111,457 | 871,000 |
Cash withdrawn from Trust Account in connection with redemption | 270,769,687 | 287,071,970 | ||
Net cash (used in) provided by investing activities | (29,352) | 271,501,165 | 287,604,733 | 871,000 |
Cash Flows from Financing Activities: | ||||
Proceeds from promissory note – related party | 69,352 | 126,030 | 578,689 | |
Repayment of promissory note – related party | (141,367) | |||
Proceeds from convertible promissory note - related party | 562,728 | 400,000 | 584,326 | 900,000 |
Redemption of common stock | (270,769,687) | (287,071,970) | ||
Net cash provided by (used in) financing activities | 632,080 | (270,243,657) | (285,908,955) | 758,633 |
Net Change in Cash | (277,377) | (10,134) | (42,715) | (17,863) |
Cash – Beginning of period | 306,034 | 348,749 | 348,749 | 366,612 |
Cash – End of period | 28,657 | 338,615 | 306,034 | 348,749 |
Supplementary cash flow information: | ||||
Excise tax payable attributable to redemption of common stock | 2,870,720 | |||
Income taxes paid | $ 464,342 | $ 448,349 | $ 448,349 | $ 511,000 |
Description of Organization and
Description of Organization and Business Operations | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Description of Organization and Business Operations [Abstract] | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Golden Arrow Merger Corp. (the “Company”) is a blank check company incorporated in Delaware on December 31, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On October 4, 2023, Beam Merger Sub, Inc. (“Merger Sub”), a Delaware corporation and a wholly-owned subsidiary of the Company, was formed. As of June 30, 2024, there has been no activity for Merger Sub. As of June 30, 2024, the Company had not commenced any operations. All activity through June 30, 2024 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on March 16, 2021. On March 19, 2021, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250,000,000 which is described in Note 3. On May 6, 2021, the Company sold 3,750,000 additional Units (the “Additional Units”) at $10.00 per Additional Unit, generating additional gross proceeds of $37,500,000, which is also described in Note 3. The Additional Units were identical to the Units sold pursuant to the Initial Public Offering. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,500,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Golden Arrow Sponsor, LLC (the “Sponsor”), generating gross proceeds of $6,750,000, which is described in Note 4. Transaction costs amounted to $16,309,469, consisting of $5,750,000 in cash underwriting fees, $10,062,500 of deferred underwriting fees and $496,969 of other offering costs. Following the closing of the Initial Public Offering on March 19, 2021, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and, until March 2023, was invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below. Following the First Extension (described below), the Company instructed the trustee with respect to the Trust Account to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in an interest-bearing demand deposit account at a bank until the earlier of consummation of an initial business combination or liquidation of the Company. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting fees and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will only proceed with a Business Combination if when the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until September 19, 2024 (the “Extended Date”) to complete a Business Combination (the “Combination Period”), subject to the Nasdaq Deadline discussed above. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. On March 18, 2024, the Company received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s securities on The Nasdaq Capital Market would be suspended at the opening of business on March 27, 2024, due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the effectiveness of its registration statement in connection with its initial public offering. The Company timely requested a hearing before the Panel, and a hearing was held on May 16, 2024, at which the Company requested sufficient time to complete the Business Combination with Bolt Threads, Inc. (“Bolt Threads”). On May 29, 2024, the Panel granted the Company’s request for an extension until September 16, 2024, which represents the full extent of the Panel’s discretion to grant continued listing while the Company is non-compliant with Nasdaq’s listing requirements (the “Nasdaq Deadline”). Failure to meet the terms of this exception will result in the Company’s immediate delist from Nasdaq. Furthermore, there can be no assurance that the Company will be able to satisfy Nasdaq’s continued listing requirements and maintain compliance with other Nasdaq listing requirements. The Company’s management identified an omission in the notes to the Company’s audited consolidated financial statements as of and for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 15, 2024 (the “Original Filing”). The Original Filing omitted certain information relating to the Company’s inadvertent disbursement of funds withdrawn from the Company’s trust account established in connection with the Company’s initial public offering (the “Trust Account”), which were restricted for payment of tax liabilities under the Company’s amended and restated certificate incorporation and the terms of the Company’s investment management trust agreement, dated March 16, 2021, for general corporate purposes. As disclosed in the Form 10-K/A, the Withdrawn Trust Funds (as defined below) were held in the Company’s operating account that also holds funds deposited by the Sponsor to be used for general operating expenses. As a result, the Company mistakenly used $157,474 of the Withdrawn Trust Funds for payment of general operating expenses as of December 31, 2023. The disclosure of this inadvertent mistake was omitted from the Company’s quarterly reports on Form 10-Q for the quarters ending June 30, 2023 and September 30, 2023. The amounts deemed to have been used for operating expenses were $76,974 as of June 30, 2023 and $335,127 as of September 30, 2023. Management has determined that this use of the Withdrawn Trust Funds was not in accordance with the trust agreement. First Extension On March 15, 2023, the Company’s stockholders approved an amendment to its amended and restated certificate of incorporation (as amended, the “charter”) (the “Charter Amendment”). The Charter Amendment extended the date by which the Company has to consummate a business combination for an additional nine months, from March 19, 2023 (the “Termination Date”) to up to December 19, 2023 by electing to extend the date to consummate an initial business combination on a monthly basis for up to nine times by an additional one month each time after the Termination Date, until December 19, 2023 or a total of up to nine months after the Termination Date, or such earlier date as determined by the Company’s board of directors, unless the closing of the initial business combination shall have occurred, which is referred to as the “First Extension,” and such later date, the “First Extended Date”, provided that the Sponsor (or its affiliates or permitted designees) will deposit into the trust account an amount determined by multiplying $0.03 by the number of public shares then outstanding, up to a maximum of $105,000 for each such one-month extension unless the closing of the Company’s initial business combination shall have occurred, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination. In connection with the votes to approve the First Extension, the holders of 26,649,519 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.16 per share, for an aggregate redemption amount of $270,769,687, leaving $21,467,825 in the Trust Account. On March 16, 2023, the Sponsor voluntarily converted the 7,047,500 shares of Class B common stock it held into 7,047,500 shares of Class A common stock in accordance with the Company’s charter (the “Conversion”). Following the implementation of the First Extension and the Conversion, the Company had 9,147,981 shares of Class A common stock outstanding and 140,000 shares of Class B common stock outstanding. Second Extension On December 12, 2023, the Company held a special meeting of stockholders (the “special meeting”) in which the stockholders approved the proposal to amend the Company’s Charter, to extend the date by which the Company has to consummate a business combination for an additional nine months from December 19, 2023 to September 19, 2024 by electing to extend the date to consummate an initial business combination on a monthly basis for up to nine times by an additional one month each time after the Termination Date, until September 19, 2024 or a total of up to nine months after the Termination Date, or such earlier date as determined by the Board, unless the closing of the Company’s initial business combination shall have occurred, which is referred to as the “Second Extension,” and such later date, the “Second Extended Date”, provided that the Sponsor (or its affiliates or permitted designees) will deposit into the Trust Account”) an amount determined by multiplying $0.02 by the number of public shares then outstanding, up to a maximum of $20,000 for each such one-month extension unless the closing of the Company’s initial business combination shall have occurred, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination (each, an “Extension Payment”). In connection with the votes to approve the Second Extension, the holders of 1,522,544 shares of Class A common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.71 per share, for an aggregate redemption amount of approximately $16.3 million, leaving approximately $6.2 million in the Trust Account. As of June 30, 2024, sixteen extension payments were made for a total of $648,046, which extended the Termination Date to July 19, 2024. On July 18, 2024, the Company made an additional payment, which extended the Termination Date to August 19, 2024. Proposed Business Combination On October 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Beam Merger Sub, Inc., incorporated on September 19, 2023, a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”) and Bolt Threads, Inc., a Delaware corporation (“Bolt Threads”). Pursuant to the Business Combination Agreement, the parties will consummate a business combination transaction pursuant to which Merger Sub will merge with and into Bolt Threads, with Bolt Threads surviving the merger as a wholly-owned subsidiary of the Company (the “Merger” and, together with the other transactions contemplated by the Business Combination Agreement, the “Business Combination” and the closing of the Business Combination, the “Closing”). In connection with the Closing, the Company will be renamed “Bolt Projects Holdings, Inc.” and is referred to herein as “the Post-Combination Company” as of the time following such change of name. The proposed Business Combination is expected to be consummated after receipt of the required approvals by the stockholders of the Company and Bolt Threads and the satisfaction or waiver of certain other customary conditions. The aggregate equity consideration to be paid to Bolt Threads’ stockholders and option holders in the Business Combination will be equal to the quotient of (i) $250,000,000 (the “Equity Value”) divided by (ii) $10.00. The Business Combination Agreement provides that, in connection with the Closing, the Post-Combination Company, certain stockholders of Bolt Threads, the Sponsor and certain stockholders of the Company will enter into an amended and restated registration rights and lock-up agreement (the “Registration Rights and Lock-up Agreement”), pursuant to which the Post-Combination Company will agree to register for resale certain shares of common stock of the Post-Combination Company (“the Post-Combination Company common stock”) and other equity securities that are held by the parties thereto from time to time. On June 10, 2024, the Company Amendment Concurrently with the execution of the Business Combination Agreement, certain investors (the “PIPE Investors”), including the Sponsor, entered into subscription agreements (as amended, the “Subscription Agreements”) pursuant to which the PIPE Investors had committed to purchase in a private placement up to 2,734,433 shares of Class A common stock (the “PIPE Shares”) at a purchase price of $10.00 per share and an aggregate purchase price of up to $27,344,330 (the “PIPE Investment”). The purchase of the PIPE Shares is conditioned upon, among other things, the consummation of the Business Combination and will be consummated immediately prior to or substantially concurrently with the Closing. The shares of Class A common stock to be issued pursuant to the Subscription Agreements have not been registered under the Securities Act and will be issued in reliance on the availability of an exemption from such registration. On February 28, 2024, the PIPE Investors entered into amendments to the Subscription Agreements which reduced their aggregate commitment to purchase PIPE Shares to 2,287,464 at a purchase price of $10.00 per share, for an aggregate PIPE Investment of up to $22,874,640. Pursuant to the PIPE Subscription Agreement executed by the Sponsor, the Sponsor had agreed to purchase 656,499 shares of Class A common stock at a purchase price of $10.00 per share for an aggregate purchase price of $6,564,990. However, the number of subscribed shares to be purchased thereunder by the Sponsor would be reduced by the number of shares of Class A common stock that have not been elected for redemption as of the expiration of the redemption period related to the Closing and that are held by certain individuals mutually agreed upon by the Company and Bolt Threads at any time from the date of the execution of the agreement up to immediately prior to the expiration of such redemption period. On June 10, 2024, the Company entered into Amendment No. 2 (the “ SA Amendment No. 2 Note Purchase Agreement Bridge III Notes As a result of the amendments described above, pursuant to the Subscription Agreements, the PIPE investors have agreed to purchase at Closing an aggregate of up to 763,144 PIPE Shares. The Sponsor has agreed to purchase up to 240,000 of the PIPE Shares and current securityholders of Bolt Threads have agreed to purchase 523,144 of the PIPE Shares. The Sponsor has committed to purchase $2,400,000 in additional convertible notes as provided in the Subscription Agreement, and any such amount of additional convertible notes purchased by the Sponsor will reduce on a dollar-for-dollar basis the amount the Sponsor is committed to invest pursuant to its Subscription Agreement by purchasing PIPE Shares. To the extent the Sponsor does not purchase all such convertible notes prior to the Sponsor Note Deadline (as defined in the Subscription Agreement) and is still obligated to purchase any PIPE Shares pursuant to its Subscription Agreement, the number of PIPE Shares to be purchased by the Sponsor will be reduced by the number of shares of Class A common stock that have not been elected for redemption as of the expiration of the redemption period related to the Closing and that are held by certain individuals mutually agreed upon by the Company and Bolt Threads at any time up to immediately prior to the expiration of such redemption period. In connection with the execution of the Business Combination Agreement, the Company entered into a sponsor support agreement (the “Sponsor Support Agreement”) with the Sponsor and Bolt Threads. Pursuant to the Sponsor Support Agreement, the Sponsor has, among other things, agreed to vote all of its shares of the Company’s capital stock in favor of the approval of the Transactions. In addition, the Sponsor had agreed that 1,437,500 shares of the Post-Combination Company common stock issued in connection with the IPO (the “Sponsor Shares”) would be unvested and subject to forfeiture as of the Closing and would only vest if, during the five year period following the Closing, (i) the volume weighted average price of the Post-Combination Company common stock equals or exceeds $12.50 (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any twenty trading days within a period of thirty consecutive trading days or (ii) there is a change of control of the Company. Any Sponsor Shares that remained unvested after the fifth anniversary of the Closing would have been forfeited. The Sponsor Support Agreement will terminate upon the earliest of (i) the effective time of the Merger, (ii) the termination of the Business Combination Agreement if the Closing does not occur, and (iii) the written agreement of the parties terminating the Sponsor Support Agreement. On June 10, 2024, the Company entered into Amendment No. 1 (the “SSA Amendment”) to the Sponsor Support Agreement to remove the provisions subjecting the Sponsor Earn-Out Shares (as defined in the Sponsor Support Agreement) to vesting and forfeiture conditions. In connection with the execution of the Business Combination Agreement, the Company entered into a support agreement (the “Stockholder Support Agreement”) with Bolt Threads and certain stockholders of Bolt Threads pursuant to which such stockholders have, among other things, agreed to vote to adopt and approve, upon the registration statement on Form S-4 being declared effective, the Business Combination Agreement and all other documents and transactions contemplated thereby and to subject their shares to certain transfer restrictions. The Stockholder Support Agreement will terminate upon the earliest of (i) the effective time of the Merger, (ii) the termination of the Business Combination Agreement if the Closing does not occur, and (iii) the written agreement of the parties terminating the Stockholder Support Agreement. On April 18, 2024, May 18, 2024, June 18, 2024 and July 18, 2024 additional extension payments of $11,559 each time were made, which extended the Termination Date to August 19, 2024. On February 2, 2024, the Company entered into an agreement with BTIG and Bolt Threads to modify the deferred underwriting fees conditioned upon the closing of the Bolt Threads Agreement. The agreement states that $500,000 will be deposited and held in the Trust Account and payable in cash directly from the Trust Account, without accrued interest, to BTIG for its own account upon consummation of the Company’s initial Business Combination. Additionally, upon consummation of the Company’s initial Business Combination, BTIG will receive shares of post-combination company common stock equivalent to the greater of: (i) 500,000 shares of post-combination company common stock, or (ii) the number of shares calculated by dividing (x) $5,000,000 by (y) the VWAP of the post-combination company common stock over the three trading days immediately preceding the initial filing of the resale registration statement, provided that clause (y) will not be less than $8.00. The deferred fee will become payable to the underwriters solely in the event that we complete the Business Combination, subject to the terms of the underwriting agreement, as amended. Upon a successful Business Combination with Bolt Threads, the Company will recognize a reduction in the value of its deferred underwriting fee equal to the $500,000 which is payable in cash and the fair value of the shares transferred as of the date of the agreement. Going Concern As of June 30, 2024, the Company had cash of $28,657 and working capital deficit of $6,959,912. The Company intends to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination. For the period ended June 30, 2024, the Company withdrew an aggregate of approximately $40,000 from the Trust Account that was used for Delaware franchise tax. The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If the Company is unable to complete the Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these unaudited consolidated financial statements are issued. In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by the Extended Date, then the Company will cease all operations except for the purpose of liquidating. The possible liquidity issues as the Company continues to incur costs and the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Golden Arrow Merger Corp. (the “Company”) is a blank check company incorporated in Delaware on December 31, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On October 4, 2023, Beam Merger Sub, Inc. (“Merger Sub I”), a Delaware corporation and a wholly owned subsidiary of the Company, was formed. As of December 31, 2023 there has been no activity for Merger Sub I. As of December 31, 2023, the Company had not commenced any operations. All activity through December 31, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on March 16, 2021. On March 19, 2021, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250,000,000 which is described in Note 3. On May 6, 2021, the Company sold 3,750,000 additional Units (the “Additional Units”) at $10.00 per Additional Unit, generating additional gross proceeds of $37,500,000, which is also described in Note 3. The Additional Units were identical to the Units sold pursuant to the Initial Public Offering. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,500,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Golden Arrow Sponsor, LLC (the “Sponsor”), generating gross proceeds of $6,750,000, which is described in Note 4. Transaction costs amounted to $16,309,469, consisting of $5,750,000 in cash underwriting fees, $10,062,500 of deferred underwriting fees and $496,969 of other offering costs. Following the closing of the Initial Public Offering on March 19, 2021, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting fees and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will only proceed with a Business Combination if when the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until September 19, 2024 (the “Extended Date”) to complete a Business Combination (the “Combination Period”). If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. First Extension On March 15, 2023, the Company’s stockholders approved an amendment to its amended and restated certificate of incorporation (as amended, the “charter”) (the “Charter Amendment”). The Charter Amendment extended the date by which the Company has to consummate a business combination for an additional nine months, from March 19, 2023 (the “Termination Date”) to up to December 19, 2023 by electing to extend the date to consummate an initial business combination on a monthly basis for up to nine times by an additional one month each time after the Termination Date, until December 19, 2023 or a total of up to nine months after the Termination Date, or such earlier date as determined by the Company’s board of directors, unless the closing of the initial business combination shall have occurred, which is referred to as the “Extension,” and such later date, the “Extended Date”, provided that the Sponsor (or its affiliates or permitted designees) will deposit into the trust account an amount determined by multiplying $0.03 by the number of public shares then outstanding, up to a maximum of $105,000 for each such one-month extension unless the closing of the Company’s initial business combination shall have occurred, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination. In connection with the votes to approve the Extension, the holders of 26,649,519 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.16 per share, for an aggregate redemption amount of $270,769,687, leaving $21,467,825 in the Trust Account. On March 16, 2023, the Sponsor voluntarily converted the 7,047,500 shares of Class B common stock it held into 7,047,500 shares of Class A common stock in accordance with the Company’s charter (the “Conversion”). Following the implementation of the Extension and the Conversion, the Company had 9,147,981 shares of Class A common stock outstanding and 140,000 shares of Class B common stock outstanding. Second Extension On December 12, 2023, the Company held a special meeting of stockholders (the “special meeting”) in which the stockholders approved the proposal to amend the Company’s Charter, to extend the date by which the Company has to consummate a business combination for an additional nine months from December 19, 2023 to September 19, 2024 by electing to extend the date to consummate an initial business combination on a monthly basis for up to nine times by an additional one month each time after the Termination Date, until September 19, 2024 or a total of up to nine months after the Termination Date, or such earlier date as determined by the board of directors (the “Board”), unless the closing of the Company’s initial business combination shall have occurred, which is referred to as the “Extension,” and such later date, the “Extended Date”, provided that the Sponsor (or its affiliates or permitted designees) will deposit into a trust account established for the benefit of the Company’s public stockholders (the “trust account”) an amount determined by multiplying $0.02 by the number of public shares then outstanding, up to a maximum of $20,000 for each such one-month extension unless the closing of the Company’s initial business combination shall have occurred, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination (each, an “Extension Payment”). In connection with the votes to approve the Extension, the holders of 1,522,544 shares of Class A common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.71 per share, for an aggregate redemption amount of approximately $16.3 million, leaving approximately $6.2 million in the trust account. As of December 31, 2023, ten extension payments were made for a total of $578,694. On January 18, 2024 and February 18, 2024, additional extension payments of $11,559 were made which extended the Termination Date to March 19, 2024. Proposed Business Combination On October 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Beam Merger Sub, Inc., incorporated on September 19, 2023, a Delaware corporation and a direct, wholly owned subsidiary of the Company (“Merger Sub”) and Bolt Threads, Inc., a Delaware corporation (“Bolt Threads”). Pursuant to the Business Combination Agreement, the parties will consummate a business combination transaction pursuant to which Merger Sub will merge with and into Bolt Threads, with Bolt Threads surviving the merger as a wholly-owned subsidiary of the Company (the “Merger” and, together with the other transactions contemplated by the Business Combination Agreement, the “Business Combination” and the closing of the Business Combination, the “Closing”). In connection with the Closing, the Company will be renamed “Bolt Projects Holdings, Inc.” and is referred to herein as “the Post-Combination Company” as of the time following such change of name. The proposed Business Combination is expected to be consummated after receipt of the required approvals by the stockholders of the Company and Bolt Threads and the satisfaction or waiver of certain other customary conditions. The aggregate equity consideration to be paid to Bolt Threads’ stockholders and option holders in the Business Combination will be equal to the quotient of (i) $250,000,000 (the “Equity Value”) divided by (ii) $10.00. The Business Combination Agreement provides that, in connection with the Closing, the Post-Combination Company, certain stockholders of Bolt Threads, the Sponsor and certain stockholders of the Company will enter into an amended and restated registration rights and lock-up agreement (the “Registration Rights and Lock-up Agreement”), pursuant to which the Post-Combination Company will agree to register for resale certain shares of common stock of the Post-Combination Company (“the Post-Combination Company common stock”) and other equity securities that are held by the parties thereto from time to time. Concurrently with the execution of the Business Combination Agreement, certain investors (the “PIPE Investors”), including the Sponsor, entered into subscription agreements (the “PIPE Subscription Agreements”) pursuant to which the PIPE Investors have committed to purchase in a private placement up to 2,734,433 shares of Class A Common Stock (the “PIPE Shares”) at a purchase price of $10.00 per share and an aggregate purchase price of up to $27,344,330 (the “PIPE Investment”). The purchase of the PIPE Shares is conditioned upon, among other things, the consummation of the Business Combination and will be consummated immediately prior to or substantially concurrently with the Closing. The shares of Class A Common Stock to be issued pursuant to the PIPE Subscription Agreements have not been registered under the Securities Act, and will be issued in reliance on the availability of an exemption from such registration. On February 28, 2024, the PIPE Investors entered into amendments to the PIPE Subscription Agreements which reduced their aggregate commitment to purchase PIPE Shares to 2,287,464 at a purchase price of $10.00 per share, for an aggregate PIPE Investment of up to $22,874,640. Pursuant to the PIPE Subscription Agreement executed by the Sponsor, the Sponsor has agreed to purchase 656,499 shares of Class A common stock at a purchase price of $10.00 per share for an aggregate purchase price of $6,564,990. However, the number of subscribed shares to be purchased thereunder by the Sponsor will be reduced by the number of shares of Class A common stock that have not been elected for redemption as of the expiration of the redemption period related to the Closing and that are held by certain individuals mutually agreed upon by the Company and Bolt Threads at any time from the date of the execution of the agreement up to immediately prior to the expiration of such redemption period. In connection with the execution of the Business Combination Agreement, the Company entered into a sponsor support agreement (the “Sponsor Support Agreement”) with the Sponsor and Bolt Threads. Pursuant to the Sponsor Support Agreement, the Sponsor has, among other things, agreed to vote all of its shares of the Company’s capital stock in favor of the approval of the Transactions. In addition, the Sponsor has agreed that 1,437,500 shares of the Post-Combination Company common stock issued in connection with the IPO (the “Sponsor Shares”) will be unvested and subject to forfeiture as of the Closing and will only vest if, during the five year period following the Closing, (i) the volume weighted average price of the Post-Combination Company common stock equals or exceeds $12.50 (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any twenty trading days within a period of thirty consecutive trading days or (ii) there is a change of control of the Company. Any Sponsor Shares that remain unvested after the fifth anniversary of the Closing will be forfeited. The Sponsor Support Agreement will terminate upon the earliest of (i) the effective time of the Merger, (ii) the termination of the Business Combination Agreement if the Closing does not occur, and (iii) the written agreement of the parties terminating the Sponsor Support Agreement. In connection with the execution of the Business Combination Agreement, the Company entered into a support agreement (the “Stockholder Support Agreement”) with Bolt Threads and certain stockholders of Bolt Threads pursuant to which such stockholders have, among other things, agreed to vote to adopt and approve, upon the registration statement on Form S-4 being declared effective, the Business Combination Agreement and all other documents and transactions contemplated thereby and to subject their shares to certain transfer restrictions. The Stockholder Support Agreement will terminate upon the earliest of (i) the effective time of the Merger, (ii) the termination of the Business Combination Agreement if the Closing does not occur, and (iii) the written agreement of the parties terminating the Stockholder Support Agreement. Going Concern As of December 31, 2023, the Company had cash of $306,034 and working capital deficit of $6,063,520. The Company intends to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination. As of December 31, 2023, the Company withdrew an aggregate of approximately $289 million from the Trust Account to be used for redemption payments in connection with the Extensions, Delaware franchise tax, and income tax obligations (the “Withdrawn Trust Funds”). The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If the Company is unable to complete the Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these consolidated financial statements are issued. In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by the Extended Date, then the Company will cease all operations except for the purpose of liquidating. The possible liquidity issues as the Company continues to incur costs and the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the Extended Date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 19, 2024, following monthly extension payments. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Summary of Significant Accounting Policies [Abstract] | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited consolidated condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited consolidated condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 15, 2024, as amended. The interim results for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods. Principles of Consolidation The accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the unaudited consolidated condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited consolidated condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2024 and December 31, 2023. Investments Held in Trust Account At June 30, 2024 and December 31, 2023, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2024 and December 31, 2023, the 577,937 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s unaudited consolidated balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. At June 30, 2024 and December 31, 2023, the Class A common stock reflected in the unaudited consolidated condensed balance sheets is reconciled in the following table: Gross proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (9,195,833 ) Class A common stock issuance costs (15,827,645 ) Plus: Accretion of carrying value to redemption value 27,881,248 Class A common stock subject to possible redemption, December 31, 2022 290,357,770 Less: Redemption (287,071,970 ) Plus: Accretion of carrying value to redemption value 2,942,345 Class A common stock subject to possible redemption, December 31, 2023 6,228,145 Plus: Accretion of carrying value to redemption value 43,863 Class A common stock subject to possible redemption, March 31, 2024 6,272,008 Plus: Accretion of carrying value to redemption value 85,456 Class A common stock subject to possible redemption, June 30, 2024 $ 6,357,464 Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to $15,827,645 were charged against their carrying value upon the completion of the Initial Public Offering, and $481,824 of the offering costs was related to the warrant liabilities and charged to the unaudited consolidated condensed statements of operations. Warrant Liabilities The Company accounts for the warrants in accordance with the guidance contained in ASC 815-40-15 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the unaudited consolidated statements of operations. The Private Placement Warrants and the public warrants (the “Public Warrants”) for periods where no observable traded price was available are valued using a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2024 and December 31, 2023, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was (2.62)% and (6.87)% for the three months ended June 30, 2024 and 2023, respectively, and 1.97% and (27.24)% for the six months ended June 30, 2024 and 2023, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2024 and 2023, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net (Loss) Income per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. The Company has two classes of shares which are referred to as Class A common stock and Class B common stock. (Loss) income is shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted (loss) income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 14,583,333 Class A common stock in the aggregate. As of June 30, 2024 and 2023, the Company had dilutive securities that are Public Warrants and Private Placement Warrants that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented. The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Three Months Ended For the Six Months Ended 2024 2024 Class A Class A Class A Class A Redeemable Non-Redeemable Class B Redeemable Non-Redeemable Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss) $ 23,707 $ 289,084 $ 5,743 $ (66,593 ) $ (812,055 ) $ (16,132 ) Denominator: Basic and diluted weighted average shares outstanding 577,937 7,047,500 140,000 577,937 7,047,500 140,000 Basic and diluted net income (loss) per common share $ 0.04 $ 0.04 $ 0.04 $ (0.12 ) $ (0.12 ) $ (0.12 ) For the Three Months Ended For the Six Months Ended 2023 2023 Class A Class A Class A Class A Redeemable Non-Redeemable Class B Redeemable Non-Redeemable Class B Basic and diluted net income per common share Numerator: Allocation of net income, $ 55,880 $ 187,488 $ 3,724 $ 153,102 $ 769,071 $ 216,786 Denominator: Basic and diluted weighted average shares outstanding 2,100,481 7,047,500 140,000 2,100,481 10,551,265 2,974,190 Basic and diluted net income per common share $ 0.03 $ 0.03 $ 0.03 $ 0.07 $ 0.07 $ 0.07 Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited consolidated balance sheets, primarily due to their short-term nature, other than derivative warrant liabilities (see Note 9). Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The adoption of ASU 2020-06 did not have a material impact on its unaudited consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its unaudited consolidated financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited consolidated financial statements. | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2023 and 2022. Investments Held in Trust Account At December 31, 2023 and 2022, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2023 and 2022, the 577,937 and 28,750,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s consolidated balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. At December 31, 2023 and 2022, the Class A common stock reflected in the consolidated balance sheets is reconciled in the following table: Gross proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (9,195,833 ) Class A common stock issuance costs (15,827,645 ) Plus: Accretion of carrying value to redemption value 27,881,248 Class A common stock subject to possible redemption, December 31, 2022 290,357,770 Less: Redemption (287,071,970 ) Plus: Accretion of carrying value to redemption value 2,942,345 Class A common stock subject to possible redemption, December 31, 2023 $ 6,228,145 Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to $15,827,645 were charged against their carrying value upon the completion of the Initial Public Offering, and $481,824 of the offering costs was related to the warrant liabilities and charged to the consolidated statements of operations. Warrant Liabilities The Company accounts for the warrants in accordance with the guidance contained in ASC 815-40-15 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the consolidated statements of operations. The Private Placement Warrants and the public warrants (the “Public Warrants”) for periods where no observable traded price was available are valued using a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of December 31, 2023 and 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was (80.17)% and 7.16% for the year ended December 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the year ended December 31, 2023 and 2022, due to changes in fair value in warrant liability, changes in fair value in the convertible promissory note, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net (Loss) Income per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. The Company has two classes of shares which are referred to as Class A common stock and Class B Common stock. (Loss) income is shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted (loss) income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 14,583,333 Class A common stock in the aggregate. As of December 31, 2023 and 2022, the Company had dilutive securities that are Public Warrants and Private Placement Warrants that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented. The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Year Ended December 31, 2023 2022 Class A Class A Class B Class A Class B Basic and diluted net (loss) income per common share Numerator: Allocation of net (loss) income, $ (782,184 ) $ (583,482 ) $ (164,960 ) $ 7,877,369 $ 1,969,342 Denominator: Basic and diluted weighted average shares outstanding 7,511,529 5,603,340 1,584,160 28,750,000 7,187,500 Basic and diluted net (loss) income per common share $ (0.10 ) $ (0.10 ) $ (0.10 ) $ 0.27 $ 0.27 Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, other than derivative warrant liabilities (see Note 9). Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The impact of the adoption of ASU 2020-06 is being assessed by the Company, however no significant impact on the consolidated financial statements is anticipated. In June 2016, the FASB issued ASU 2016-13 — “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements. |
Public Offering
Public Offering | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Public Offering [Abstract] | ||
PUBLIC OFFERING | NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9). On May 6, 2021, the Company sold 3,750,000 Additional Units at $10.00 per Additional Unit. The Additional Units were identical to the Units sold pursuant to the Initial Public Offering. | NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9). On May 6, 2021, the Company sold 3,750,000 Additional Units at $10.00 per Additional Unit. The Additional Units were identical to the Units sold pursuant to the Initial Public Offering. |
Private Placement
Private Placement | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Private Placement [Abstract] | ||
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 4,500,000 Private Placement Warrants, at a price of $1.50 per warrant, or $6,750,000 in the aggregate. On May 6, 2021, simultaneously with the sale of the Additional Units, the Company consummated the sale of an additional 500,000 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, or $750,000 in the aggregate, if the over-allotment option is exercised in full or in part by the underwriters. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 9). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 4,500,000 Private Placement Warrants, at a price of $1.50 per warrant, or $6,750,000 in the aggregate. On May 6, 2021, simultaneously with the sale of the Additional Units, the Company consummated the sale of an additional 500,000 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, or $750,000 in the aggregate, if the over-allotment option is exercised in full or in part by the underwriters. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 9). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. |
Related Party Transactions
Related Party Transactions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Related Party Transactions [Abstract] | ||
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In January 2021, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration for the issuance of 7,187,500 shares of the Company’s Class B common stock (the “Founder Shares”). The Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. As a result of the underwriters’ full exercise of their over-allotment option on May 6, 2021, no The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party In connection with the Extension Payments, on March 17, 2023, the Company issued an unsecured promissory note to the Sponsor in the aggregate amount of $567,130 (the “Extension Note”). As of June 30, 2024, the Company has deposited an aggregate of $567,130 of Extension Payments into the Trust Account and has extended the Termination Date up to August19, 2024. The Extension Note bears no interest and the principal balance is payable on the date of the consummation of the initial business combination. The Extension Note is not convertible into private placement warrants and the principal balance may be prepaid at any time. As of June 30, 2024, $567,130 was outstanding under this note. On December 18, 2023, the Company issued an unsecured promissory note to our Sponsor in the aggregate amount of $104,029 (the “Extension Note 2”). As of June 30, 2024, the Company has deposited an aggregate of $80,911 of Extension Payments into the Trust Account and intends to continue to extend the Termination Date up to September 19, 2024. The Extension Note bears no interest and the principal balance is payable on the date of the consummation of the initial business combination. The Extension Note is not convertible into private placement warrants and the principal balance may be prepaid at any time. As of June 30, 2024 and December 31, 2023, there was an aggregate of $648,041 and $578,689 outstanding, respectively, under the two related party promissory notes (together, the “Extension Notes”). The Extension Promissory Notes were valued at par value. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants. On February 25, 2022, the Company issued a promissory note to the Sponsor pursuant to which it may borrow up to an aggregate principal amount of $500,000. The promissory note is non-interest bearing and payable upon the consummation of a Business Combination. At the Sponsor’s discretion, the promissory note may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. On August 26, 2022, the Company issued a second promissory note to the Sponsor pursuant to which it may borrow up to an aggregate principal amount of $400,000. The promissory note is non-interest bearing and payable upon the consummation of a Business Combination. At the Sponsor’s discretion, the promissory note may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. On March 8, 2023, the Company issued a third promissory note to which it may borrow up to an aggregate principal amount of $750,000. The promissory note is non-interest bearing and payable upon the consummation of a Business Combination. At the Sponsor’s discretion, the promissory note may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant, provided that the aggregate of such warrants, together with any warrants issued upon conversions pursuant to the promissory notes dated February 25, 2022 and August 26, 2022, do not exceed 1,000,000 warrants. The warrants would be identical to the Private Placement Warrants. On April 3, 2024, the Company issued an unsecured promissory note, in the amount of up to $510,000 to Golden Arrow Sponsor, LLC (the “Sponsor”). The proceeds of the note may be drawn down from time to time prior to the Maturity Date (as defined below) upon request by the Company. The note bears no interest and the principal balance is payable on the date of the consummation of the Company’s initial business combination (the “Maturity Date”). On or before the Maturity Date, the Sponsor has the option to convert all or any portion of the principal outstanding under the Note into warrants (“Working Capital Warrants”) at a conversion price of $1.50 per warrant, provided that the aggregate of such Working Capital Warrants, together with any warrants issued upon conversions pursuant to the promissory notes, dated February 25, 2022, August 26, 2022 and March 8, 2023, do not exceed 1,000,000 warrants. The terms of the Working Capital Warrants, if any, would be identical to the terms of the private placement warrants issued by the Company at the time of its initial public offering (the “IPO”), as described in the prospectus for the IPO dated March 16, 2021 and filed with the U.S. Securities and Exchange Commission (the “SEC”), including the transfer restrictions applicable thereto. The Note is subject to customary events of default, the occurrence of certain of which automatically triggers the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. The issuance of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. As of June 30, 2024, $510,000 was outstanding under this note. The Company has determined that bifurcation of a single derivative that comprises all of the fair value of the conversion feature (i.e., derivative instrument) is necessary under ASC 815-15-25-7 through 25-10. As a result the derivative value was deemed to be de minimus at the issuance date and at each subsequent reporting date resulting in no change in the value of the derivative. The derivative will continue to be monitored and measured at each reporting period until the notes are settled. As of June 30, 2024 and December 31, 2023, there was an aggregate of $2,047,054 and $1,484,326 outstanding, respectively, under the four promissory notes (together, the “Convertible Promissory Notes”). The Convertible Promissory Notes were valued at par value. | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In January 2021, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration for the issuance of 7,187,500 shares of the Company’s Class B common stock (the “Founder Shares”). The Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. As a result of the underwriters’ full exercise of their over-allotment option on May 6, 2021, no The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party In connection with the Extension Payments, on March 17, 2023, the Company issued an unsecured promissory note to the Sponsor in the aggregate amount of $567,130 (the “Extension Note”). As of December 31, 2023, the Company has deposited an aggregate of $567,130 of Extension Payments into the Trust Account and intends to continue to extend the Termination Date up to March 19, 2024. The Extension Note bears no interest and the principal balance is payable on the date of the consummation of the initial business combination. The Extension Note is not convertible into private placement warrants and the principal balance may be prepaid at any time. As of December 31, 2023, $567,130 was outstanding under this note. On December 18, 2023, the Company issued an unsecured promissory note to our Sponsor in the aggregate amount of $104,029 (the “Extension Note 2”). As of December 31, 2023, the Company has deposited an aggregate of $11,559 of Extension Payments into the Trust Account and intends to continue to extend the Termination Date up to September 19, 2024. The Extension Note bears no interest and the principal balance is payable on the date of the consummation of the initial business combination. The Extension Note is not convertible into private placement warrants and the principal balance may be prepaid at any time. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants. On February 25, 2022, the Company issued a promissory note to the Sponsor pursuant to which it may borrow up to an aggregate principal amount of $500,000. The promissory note is non-interest bearing and payable upon the consummation of a Business Combination. At the Sponsor’s discretion, the promissory note may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. On August 26, 2022, the Company issued a second promissory note to the Sponsor pursuant to which it may borrow up to an aggregate principal amount of $400,000. The promissory note is non-interest bearing and payable upon the consummation of a Business Combination. At the Sponsor’s discretion, the promissory note may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. On March 8, 2023, the Company issued a third promissory note to which it may borrow up to an aggregate principal amount of $750,000. The promissory note is non-interest bearing and payable upon the consummation of a Business Combination. At the Sponsor’s discretion, the promissory note may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant, provided that the aggregate of such warrants, together with any warrants issued upon conversions pursuant to the promissory notes dated February 25, 2022 and August 26, 2022, do not exceed 1,000,000 warrants. The warrants would be identical to the Private Placement Warrants. The Company has determined that bifurcation of a single derivative that comprises all of the fair value of the conversion feature (i.e., derivative instrument) is necessary under ASC 815-15-25-7 through 25-10. As a result the derivative value was deemed to be de minimus at the issuance date and at each subsequent reporting date resulting in no change in the value of the derivative. The derivative will continue to be monitored and measured at each reporting period until the notes are settled. As of December 31, 2023 and 2022, there was an aggregate of $1,484,326 and $88,850 outstanding under the three promissory notes (together, the “Convertible Promissory Notes”), respectively. The Convertible Promissory Notes were valued at par value. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Commitments and Contingencies [Abstract] | ||
COMMITMENTS AND CONTINGENCIES | NOTE 6. COMMITMENTS Risks and Uncertainties The continuing military conflict between the Russian Federation and Ukraine, the military action between Hamas and Israel and the risk of escalations of other military conflicts have created and are expected to create global economic consequences. The specific impact on the Company’s financial condition, results of operations, and cash flows is not determinable as of the date of these unaudited consolidated condensed financial statements. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. During the second quarter, the IRS issued final regulations with respect to the timing and payment of the excise tax. Pursuant to those regulations, the Company would need to file a return and remit payment for any liability incurred during the period from January 1, 2023 to December 31, 2023 on or before October 31, 2024. The Company is currently evaluating its options with respect to payment of this obligation. If the Company is unable to pay its obligation in full, it will be subject to additional interest and penalties which are currently estimated at 10% interest per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid from November 1, 2024 until paid in full. Registration Rights Pursuant to a registration rights agreement entered into on March 16, 2021, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) have registration rights to require the Company to register a sale of any of the securities held by them. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,062,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On February 2, 2024, the Company entered into an agreement with BTIG and Bolt Threads to modify the deferred underwriting fees conditioned upon the closing of the Bolt Threads Agreement. The agreement states that $500,000 will be deposited and held in the Trust Account and payable in cash directly from the Trust Account, without accrued interest, to BTIG for its own account upon consummation of the Company’s initial Business Combination. Additionally, upon consummation of the Company’s initial Business Combination, BTIG will receive shares of post-combination company common stock equivalent to the greater of: (i) 500,000 shares of post-combination company common stock, or (ii) the number of shares calculated by dividing (x) $5,000,000 by (y) the VWAP of the post-combination company common stock over the three trading days immediately preceding the initial filing of the resale registration statement, provided that clause (y) will not be less than $8.00. The deferred fee will become payable to the underwriters solely in the event that we complete the Business Combination, subject to the terms of the underwriting agreement, as amended. Upon a successful Business Combination with Bolt Threads, the Company will recognize a reduction in the value of its deferred underwriting fee equal to the $500,000 which is payable in cash and the fair value of the shares transferred as of the date of the agreement. Consulting Agreement On June 20, 2022, the Company entered into an agreement with Jones International Group for consulting services related to a search for a target business. For the three and six months ended June 30, 2024, the Company incurred $0 in these consulting fees. For the three and six months ended June 30, 2023, the Company incurred $20,500 in these consulting fees. On February 20, 2023, the Company terminated this agreement. | NOTE 6. COMMITMENTS Risks and Uncertainties The continuing military conflict between the Russian Federation and Ukraine, the military action between Hamas and Israel and the risk of escalations of other military conflicts have created and are expected to create global economic consequences. The specific impact on the Company’s financial condition, results of operations, and cash flows is not determinable as of the date of these consolidated financial statements. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Registration Rights Pursuant to a registration rights agreement entered into on March 16, 2021, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) have registration rights to require the Company to register a sale of any of the securities held by them. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,062,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Side Letter Agreements Pursuant to side letter agreements entered into with each of Propoenent LLC and Siddhartha Mukherjee, as compensation for the introduction of the Company to a target company, not previously known to the Company and with which the Company ultimately consummates its initial Business Combination, the Sponsor will either issue a membership interest in the Sponsor representing an economic interest in 100,000 of the Founder Shares or transfer 100,000 of the Founders Shares. As of December 31, 2023 and 2022, this compensation was deemed to not have been earned. Consulting Agreement On June 20, 2022, the Company entered into an agreement with Jones International Group for consulting services related to a search for a target business. For the year ended December 31, 2023, the Company incurred $20,500 in these consulting fees. On February 20, 2023, the Company terminated this agreement. |
Stockholders_ Deficit
Stockholders’ Deficit | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Stockholders’ Deficit [Abstract] | ||
STOCKHOLDERS’ DEFICIT | NOTE 7. STOCKHOLDERS’ DEFICIT Preferred Stock Class A Common Stock Class B Common Stock Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of stockholders except as otherwise required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the total number of all shares of common stock outstanding upon completion of the Proposed Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination. | NOTE 7. STOCKHOLDERS’ DEFICIT Preferred Stock no Class A Common Stock Class B Common Stock Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of stockholders except as otherwise required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the total number of all shares of common stock outstanding upon completion of the Proposed Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination. |
Warrants
Warrants | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Warrants [Abstract] | ||
WARRANTS | NOTE 8. WARRANTS Warrants The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00. ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption, or 30 day redemption period, to each warrant holder; and ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00. ● in whole and not in part; ● at a price of $0.10 per warrant provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock based on the redemption date and the fair market value of the Class A common stock; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s Business Combination on the date of the completion of such Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $10.00 and $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. As of June 30, 2024 and December 31, 2023, there were 5,000,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or its permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. | NOTE 8. WARRANTS Warrants five The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00. ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption, or 30 day redemption period, to each warrant holder; and ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00. ● in whole and not in part; ● at a price of $0.10 per warrant provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock based on the redemption date and the fair market value of the Class A common stock; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s Business Combination on the date of the completion of such Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $10.00 and $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. As of December 31, 2023 and 2022, there were 5,000,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or its permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. |
Income Tax
Income Tax | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax [Abstract] | |
INCOME TAX | NOTE 9. INCOME TAX The Company’s net deferred tax assets are as follows: December 31, December 31, Deferred tax assets Net operating loss carryforward $ — $ — Startup/Organization Expenses 838,918 412,939 Total deferred tax assets 838,918 412,939 Valuation allowance (838,918 ) (412,939 ) Deferred tax assets, net of allowance $ — $ — The income tax provision consists of the following: December 31, December 31, Federal Current $ 653,044 $ 759,647 Deferred (425,978 ) (201,748 ) State Current — — Deferred — — Change in valuation allowance 425,978 201,748 Income tax provision $ 653,044 $ 759,647 As of December 31, 2023 and 2022, the Company had $0 and $0 U.S. federal and state net operating loss carryovers available to offset future taxable income, respectively. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the years ended December 31, 2023 and 2022, the change in the valuation allowance were $425,978 and $201,748, respectively. A reconciliation of the federal income tax rate to the Company’s effective tax rate for the years ended December 31, 2023 and 2022 is as follows: December 31, December 31, Statutory federal income tax rate 21.0 % 21.0 % State taxes, net of federal tax benefit 0.0 % 0.0 % Change in fair value of warrants (48.9 )% (14.1 )% Transaction costs associated with the Initial Public Offering 0.0 % 0.0 % Change in fair value of convertible promissory note – related party 0.0 % (1.7 )% Change in valuation allowance (52.3 )% 1.9 % Income tax provision (80.2 )% 7.1 % The Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination by the various taxing authorities. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Fair Value Measurements [Abstract] | ||
FAIR VALUE MEASUREMENTS | NOTE 9. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at June 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level June 30, December 31, Liabilities: Warrant Liabilities – Public Warrants 2 $ 1,437,500 $ 1,341,667 Warrant Liabilities – Private Placement Warrants 3 $ 750,000 $ 700,000 Warrant Liabilities The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Company’s accompanying unaudited consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the unaudited consolidated statements of operations. For the Public Warrants, the Company initially utilized a binomial lattice model consistent with the Private Warrants discussed below. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 due to the use of an observable market quote in an active market. For the Private Placement Warrants, the Company utilizes a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology, to value the warrants at each reporting period, with changes in fair value recognized in the unaudited consolidated statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its shares of common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The key inputs for the binomial lattice model as of June 30, 2024 and December 31, 2023 were as follows: Input As of As of Stock price $ 11.04 $ 10.58 Strike price $ 11.50 $ 11.50 Effective expiration date September 17, 2024 September 17, 2024 Volatility Immaterial Immaterial % Risk-free rate 4.90 % 4.34 % Dividend yield 0.0 % 0.0 % The following tables present the changes in the fair value of warrant liabilities classified as Level 3 in the fair value hierarchy as June 30, 2024 and 2023: Private Fair value as of January 1, 2024 $ 700,000 Change in valuation inputs or other assumptions 300,000 Fair value as of March 31, 2024 $ 1,000,000 Change in valuation inputs or other assumptions (250,000 ) Fair value as of June 30, 2024 $ 750,000 Private Fair value as of January 1, 2023 $ 50,000 Change in valuation inputs or other assumptions 200,000 Fair value as of March 31, 2023 $ 250,000 Change in valuation inputs or other assumptions (100,000 ) Fair value as of June 30, 2023 $ 150,000 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers in or out of Level 3 from other levels in the fair value hierarchy that occurred during the three and six months ended June 30, 2024 and 2023. The Public Warrants were transferred from Level 1 to Level 2 at December 31, 2022 due to the lack of trading activity. | NOTE 10. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on an assessment of the assumptions that market participants would use in pricing the asset or liability. At December 31, 2023, assets held in the Trust Account were comprised of $6,218,429 in money market funds which are primarily invested in U.S. Treasury securities. During the year ended December 31, 2023, the Company withdrew an aggregate of $288,183,427 from the Trust Account be used for redemption payments in connection with the Extension, Delaware franchise tax, and income tax obligations. At December 31, 2022, assets held in the Trust Account were comprised of $290,646,467 in money market funds which are primarily invested in U.S. Treasury securities. During the year ended December 31, 2022, the Company withdrew $871,000 in interest income from the Trust Account. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its money market investments held in the Trust Account. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2023 and 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, December 31, Assets: Investments held in Trust Account 1 $ 6,218,429 $ 290,646,467 Liabilities: Warrant Liabilities – Public Warrants 2 $ 1,341,667 $ 95,833 Warrant Liabilities – Private Placement Warrants 3 $ 700,000 $ 50,000 Convertible promissory notes – related party 3 $ n/a $ 88,850 Warrant Liabilities The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Company’s accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations. For the Public Warrants, the Company initially utilized a binomial lattice model consistent with the Private Warrants discussed below. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 due to the use of an observable market quote in an active market. For the Private Placement Warrants, the Company utilizes a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology, to value the warrants at each reporting period, with changes in fair value recognized in the consolidated statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its shares of common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The key inputs for the binomial lattice model as of December 31, 2023 and 2022 were as follows: Input As of As of Stock price $ 10.58 $ 10.02 Strike price $ 11.50 $ 11.50 Effective expiration date September 17, 2024 September 17, 2023 Volatility Immaterial 7.0 % Risk-free rate 4.34 % 4.69 % Dividend yield 0.0 % 0.0 % The following tables present the changes in the fair value of warrant liabilities classified as Level 3 in the fair value hierarchy as of December 31, 2023 and 2022: Private Fair value as of January 1, 2023 $ 50,000 Change in valuation inputs or other assumptions 650,000 Fair value as of December 31, 2023 $ 700,000 Private Fair value as of January 1, 2022 $ 2,497,500 Change in valuation inputs or other assumptions (2,447,500 ) Fair value as of December 31, 2022 $ 50,000 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers in or out of Level 3 from other levels in the fair value hierarchy that occurred during the year ended December 31, 2023 and 2022. The Public Warrants were transferred from Level 1 to Level 2 at December 31, 2022 due to the lack of trading activity. Convertible Promissory Notes — Related Party The fair value of the option to convert the convertible promissory notes into Private Warrants was valued by utilizing a discounted cash flow method to value the debt component and a Black-Scholes model to value the debt conversion option to derive the fair value of the convertible notes. The estimated fair value of the convertible promissory notes was based on the following significant inputs: Input As of Stock price $ 10.02 Strike price $ 11.50 Expiration date of warrants September 17, 2023 Volatility 7.0 % Risk-free rate 4.69 % Dividend yield 0.0 % The following tables present the changes in the fair value of the Level 3 convertible promissory notes: Fair value as of January 1, 2023 $ 88,850 Restatement of Convertible Promissory Note (88,850 ) Fair value as of December 31, 2023 $ — Fair value as of January 1, 2022 $ — Proceeds received through Convertible Promissory Note 900,000 Change in fair value (811,150 ) Fair value as of December 31, 2022 $ 88,850 There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the year ended December 31, 2023 and 2022 for the convertible promissory notes. |
Franchise and Income Tax Withdr
Franchise and Income Tax Withdrawal | 12 Months Ended |
Dec. 31, 2023 | |
Franchise and Income Tax Withdrawal [Abstract] | |
FRANCHISE AND INCOME TAX WITHDRAWAL | NOTE 11. FRANCHISE AND INCOME TAX WITHDRAWAL Since the completion of its IPO on March 19, 2021, and through December 31, 2023, the Company withdrew $1,982,457 from the Trust Account to pay liabilities related to the income and Delaware franchise taxes. Through December 31, 2023, the Company remitted $1,518,949 to the respective tax authorities, which resulted in remaining excess funds withdrawn from the Trust Account but not remitted to the government authorities of $463,508. Additionally, the Withdrawn Trust Funds were held in the Company’s operating account that also holds funds deposited by the Sponsor to be used for general operating expenses. As a result, the Company mistakenly used $157,474 of the Withdrawn Trust Funds for payment of general operating expenses as of December 31, 2023. The disclosure of this inadvertent mistake was omitted from the Company’s quarterly reports on Form 10-Q for the quarters ended June 30, 2023 and September 30, 2023. The amounts deemed to have been used for operating expenses were $76,974 as of June 30, 2023 and $335,127 as of September 30, 2023. Management has determined that this use of the Withdrawn Trust Funds was not in accordance with the Trust Agreement. On April 3, 2024, the Company issued a non-interest bearing, unsecured promissory note to the Sponsor, pursuant to which it may borrow up to an aggregate principal amount of $510,000, which made the Withdrawn Trust Funds whole. The Company made estimated payments on its income tax obligations for the year ended December 31, 2023 of $453,342 and $11,000 on April 3, 2024 and April 9, 2024, respectively. The promissory note replenished the Company’s operating account for the Withdrawn Trust Funds inadvertently used for operating expenses. The Company is in the process of establishing a restricted bank account to be used to temporarily hold future withdrawals from the Trust Account, if any, for Delaware franchise tax and income tax obligations. |
Subsequent Events
Subsequent Events | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Subsequent Events [Abstract] | ||
SUBSEQUENT EVENTS | NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the unaudited consolidated condensed balance sheet date up to the date that the unaudited consolidated condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than below, that would have required adjustment or disclosure in the unaudited consolidated condensed financial statements. On July 11, 2024, the Company issued an unsecured promissory note in the amount of $220,000 with the Sponsor. The note bears no interest and is payable upon consummation of the Company’s business combination. The Sponsor has the option to convert all or any portion of the principal outstanding under the Note into warrants (“Working Capital Warrants”) at a conversion price of $1.50 per warrant, provided that the aggregate of such Working Capital Warrants, together with any warrants issued upon conversions pursuant to the promissory notes, dated February 25, 2022, August 26, 2022, March 8, 2023 and April 3, 2024, do not exceed 1,000,000 warrants. The note was fully drawn on July 11, 2024. The registration statement on Form S-4, as amended, relating to the Business Combination was declared effective by the SEC on July 18, 2024. On July 18, 2024, we mailed a definitive proxy statement/prospectus to our stockholders in connection with a special meeting of stockholders to be held on August 9, 2024, for our stockholders to approve the Business Combination Agreement and related transactions. | NOTE 12. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than below, that would have required adjustment or disclosure in the consolidated financial statements. On January 18, 2024 and February 18, 2024, additional extension payments of $11,559 were made which extended the Termination Date to March 19, 2024. On February 2, 2024, the Company, BTIG and Bolt Threads entered into an amendment to the underwriting agreement, pursuant to which $500,000 will be deposited and held in the Trust Account and payable in cash directly from the Trust Account, without accrued interest, to BTIG for its own account upon consummation of the Company’s initial Business Combination. Additionally, upon consummation of the Company’s initial Business Combination, BTIG will receive shares of post-combination company common stock equivalent to the greater of: (i) 500,000 shares of post-combination company common stock, or (ii) the number of shares calculated by dividing (x) $5,000,000 by (y) the VWAP of the post-combination company common stock over the three trading days immediately preceding the initial filing of the resale registration statement, provided that clause (y) will not be less than $8.00. The deferred fee will become payable to the underwriters solely in the event that we complete the Business Combination, subject to the terms of the underwriting agreement, as amended. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Summary of Significant Accounting Policies [Abstract] | ||
Basis of Presentation | Basis of Presentation The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited consolidated condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited consolidated condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 15, 2024, as amended. The interim results for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods. | Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). |
Principles of Consolidation | Principles of Consolidation The accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. | Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the unaudited consolidated condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited consolidated condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. | Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2024 and December 31, 2023. | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2023 and 2022. |
Investments Held in Trust Account | Investments Held in Trust Account At June 30, 2024 and December 31, 2023, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. | Investments Held in Trust Account At December 31, 2023 and 2022, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2024 and December 31, 2023, the 577,937 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s unaudited consolidated balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. At June 30, 2024 and December 31, 2023, the Class A common stock reflected in the unaudited consolidated condensed balance sheets is reconciled in the following table: Gross proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (9,195,833 ) Class A common stock issuance costs (15,827,645 ) Plus: Accretion of carrying value to redemption value 27,881,248 Class A common stock subject to possible redemption, December 31, 2022 290,357,770 Less: Redemption (287,071,970 ) Plus: Accretion of carrying value to redemption value 2,942,345 Class A common stock subject to possible redemption, December 31, 2023 6,228,145 Plus: Accretion of carrying value to redemption value 43,863 Class A common stock subject to possible redemption, March 31, 2024 6,272,008 Plus: Accretion of carrying value to redemption value 85,456 Class A common stock subject to possible redemption, June 30, 2024 $ 6,357,464 | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2023 and 2022, the 577,937 and 28,750,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s consolidated balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. At December 31, 2023 and 2022, the Class A common stock reflected in the consolidated balance sheets is reconciled in the following table: Gross proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (9,195,833 ) Class A common stock issuance costs (15,827,645 ) Plus: Accretion of carrying value to redemption value 27,881,248 Class A common stock subject to possible redemption, December 31, 2022 290,357,770 Less: Redemption (287,071,970 ) Plus: Accretion of carrying value to redemption value 2,942,345 Class A common stock subject to possible redemption, December 31, 2023 $ 6,228,145 |
Offering Costs | Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to $15,827,645 were charged against their carrying value upon the completion of the Initial Public Offering, and $481,824 of the offering costs was related to the warrant liabilities and charged to the unaudited consolidated condensed statements of operations. | Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to $15,827,645 were charged against their carrying value upon the completion of the Initial Public Offering, and $481,824 of the offering costs was related to the warrant liabilities and charged to the consolidated statements of operations. |
Warrant Liabilities | Warrant Liabilities The Company accounts for the warrants in accordance with the guidance contained in ASC 815-40-15 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the unaudited consolidated statements of operations. The Private Placement Warrants and the public warrants (the “Public Warrants”) for periods where no observable traded price was available are valued using a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. | Warrant Liabilities The Company accounts for the warrants in accordance with the guidance contained in ASC 815-40-15 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the consolidated statements of operations. The Private Placement Warrants and the public warrants (the “Public Warrants”) for periods where no observable traded price was available are valued using a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2024 and December 31, 2023, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was (2.62)% and (6.87)% for the three months ended June 30, 2024 and 2023, respectively, and 1.97% and (27.24)% for the six months ended June 30, 2024 and 2023, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2024 and 2023, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. | Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of December 31, 2023 and 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was (80.17)% and 7.16% for the year ended December 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the year ended December 31, 2023 and 2022, due to changes in fair value in warrant liability, changes in fair value in the convertible promissory note, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Net (Loss) Income per Common Share | Net (Loss) Income per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. The Company has two classes of shares which are referred to as Class A common stock and Class B common stock. (Loss) income is shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted (loss) income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 14,583,333 Class A common stock in the aggregate. As of June 30, 2024 and 2023, the Company had dilutive securities that are Public Warrants and Private Placement Warrants that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented. The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Three Months Ended For the Six Months Ended 2024 2024 Class A Class A Class A Class A Redeemable Non-Redeemable Class B Redeemable Non-Redeemable Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss) $ 23,707 $ 289,084 $ 5,743 $ (66,593 ) $ (812,055 ) $ (16,132 ) Denominator: Basic and diluted weighted average shares outstanding 577,937 7,047,500 140,000 577,937 7,047,500 140,000 Basic and diluted net income (loss) per common share $ 0.04 $ 0.04 $ 0.04 $ (0.12 ) $ (0.12 ) $ (0.12 ) For the Three Months Ended For the Six Months Ended 2023 2023 Class A Class A Class A Class A Redeemable Non-Redeemable Class B Redeemable Non-Redeemable Class B Basic and diluted net income per common share Numerator: Allocation of net income, $ 55,880 $ 187,488 $ 3,724 $ 153,102 $ 769,071 $ 216,786 Denominator: Basic and diluted weighted average shares outstanding 2,100,481 7,047,500 140,000 2,100,481 10,551,265 2,974,190 Basic and diluted net income per common share $ 0.03 $ 0.03 $ 0.03 $ 0.07 $ 0.07 $ 0.07 | Net (Loss) Income per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. The Company has two classes of shares which are referred to as Class A common stock and Class B Common stock. (Loss) income is shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted (loss) income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 14,583,333 Class A common stock in the aggregate. As of December 31, 2023 and 2022, the Company had dilutive securities that are Public Warrants and Private Placement Warrants that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented. The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Year Ended December 31, 2023 2022 Class A Class A Class B Class A Class B Basic and diluted net (loss) income per common share Numerator: Allocation of net (loss) income, $ (782,184 ) $ (583,482 ) $ (164,960 ) $ 7,877,369 $ 1,969,342 Denominator: Basic and diluted weighted average shares outstanding 7,511,529 5,603,340 1,584,160 28,750,000 7,187,500 Basic and diluted net (loss) income per common share $ (0.10 ) $ (0.10 ) $ (0.10 ) $ 0.27 $ 0.27 |
Concentration of Credit Risk | Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. | Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited consolidated balance sheets, primarily due to their short-term nature, other than derivative warrant liabilities (see Note 9). | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, other than derivative warrant liabilities (see Note 9). |
Recent Accounting Standards | Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The adoption of ASU 2020-06 did not have a material impact on its unaudited consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its unaudited consolidated financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited consolidated financial statements. | Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The impact of the adoption of ASU 2020-06 is being assessed by the Company, however no significant impact on the consolidated financial statements is anticipated. In June 2016, the FASB issued ASU 2016-13 — “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Tables) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Summary of Significant Accounting Policies [Abstract] | ||
Schedule of Class A Common Stock Reflected in the Consolidated Condensed Balance Sheet | At June 30, 2024 and December 31, 2023, the Class A common stock reflected in the unaudited consolidated condensed balance sheets is reconciled in the following table: Gross proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (9,195,833 ) Class A common stock issuance costs (15,827,645 ) Plus: Accretion of carrying value to redemption value 27,881,248 Class A common stock subject to possible redemption, December 31, 2022 290,357,770 Less: Redemption (287,071,970 ) Plus: Accretion of carrying value to redemption value 2,942,345 Class A common stock subject to possible redemption, December 31, 2023 6,228,145 Plus: Accretion of carrying value to redemption value 43,863 Class A common stock subject to possible redemption, March 31, 2024 6,272,008 Plus: Accretion of carrying value to redemption value 85,456 Class A common stock subject to possible redemption, June 30, 2024 $ 6,357,464 | At December 31, 2023 and 2022, the Class A common stock reflected in the consolidated balance sheets is reconciled in the following table: Gross proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (9,195,833 ) Class A common stock issuance costs (15,827,645 ) Plus: Accretion of carrying value to redemption value 27,881,248 Class A common stock subject to possible redemption, December 31, 2022 290,357,770 Less: Redemption (287,071,970 ) Plus: Accretion of carrying value to redemption value 2,942,345 Class A common stock subject to possible redemption, December 31, 2023 $ 6,228,145 |
Schedule of Basic and Diluted Net (Loss) Income Per Common Share | The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Three Months Ended For the Six Months Ended 2024 2024 Class A Class A Class A Class A Redeemable Non-Redeemable Class B Redeemable Non-Redeemable Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss) $ 23,707 $ 289,084 $ 5,743 $ (66,593 ) $ (812,055 ) $ (16,132 ) Denominator: Basic and diluted weighted average shares outstanding 577,937 7,047,500 140,000 577,937 7,047,500 140,000 Basic and diluted net income (loss) per common share $ 0.04 $ 0.04 $ 0.04 $ (0.12 ) $ (0.12 ) $ (0.12 ) For the Three Months Ended For the Six Months Ended 2023 2023 Class A Class A Class A Class A Redeemable Non-Redeemable Class B Redeemable Non-Redeemable Class B Basic and diluted net income per common share Numerator: Allocation of net income, $ 55,880 $ 187,488 $ 3,724 $ 153,102 $ 769,071 $ 216,786 Denominator: Basic and diluted weighted average shares outstanding 2,100,481 7,047,500 140,000 2,100,481 10,551,265 2,974,190 Basic and diluted net income per common share $ 0.03 $ 0.03 $ 0.03 $ 0.07 $ 0.07 $ 0.07 | The following table reflects the calculation of basic and diluted net (loss) income per common share For the Year Ended December 31, 2023 2022 Class A Class A Class B Class A Class B Basic and diluted net (loss) income per common share Numerator: Allocation of net (loss) income, $ (782,184 ) $ (583,482 ) $ (164,960 ) $ 7,877,369 $ 1,969,342 Denominator: Basic and diluted weighted average shares outstanding 7,511,529 5,603,340 1,584,160 28,750,000 7,187,500 Basic and diluted net (loss) income per common share $ (0.10 ) $ (0.10 ) $ (0.10 ) $ 0.27 $ 0.27 |
Income Tax (Tables)
Income Tax (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax [Abstract] | |
Schedule of Net Deferred Tax Assets | The Company’s net deferred tax assets are as follows: December 31, December 31, Deferred tax assets Net operating loss carryforward $ — $ — Startup/Organization Expenses 838,918 412,939 Total deferred tax assets 838,918 412,939 Valuation allowance (838,918 ) (412,939 ) Deferred tax assets, net of allowance $ — $ — |
Schedule of Income Tax Provision | The income tax provision consists of the following: December 31, December 31, Federal Current $ 653,044 $ 759,647 Deferred (425,978 ) (201,748 ) State Current — — Deferred — — Change in valuation allowance 425,978 201,748 Income tax provision $ 653,044 $ 759,647 |
Schedule of Reconciliation of the Federal Income Tax Rate | A reconciliation of the federal income tax rate to the Company’s effective tax rate for the years ended December 31, 2023 and 2022 is as follows: December 31, December 31, Statutory federal income tax rate 21.0 % 21.0 % State taxes, net of federal tax benefit 0.0 % 0.0 % Change in fair value of warrants (48.9 )% (14.1 )% Transaction costs associated with the Initial Public Offering 0.0 % 0.0 % Change in fair value of convertible promissory note – related party 0.0 % (1.7 )% Change in valuation allowance (52.3 )% 1.9 % Income tax provision (80.2 )% 7.1 % |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2024 | Dec. 31, 2023 | |
Fair Value Measurements (Tables) [Line Items] | ||
Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis | The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at June 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level June 30, December 31, Liabilities: Warrant Liabilities – Public Warrants 2 $ 1,437,500 $ 1,341,667 Warrant Liabilities – Private Placement Warrants 3 $ 750,000 $ 700,000 | The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2023 and 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, December 31, Assets: Investments held in Trust Account 1 $ 6,218,429 $ 290,646,467 Liabilities: Warrant Liabilities – Public Warrants 2 $ 1,341,667 $ 95,833 Warrant Liabilities – Private Placement Warrants 3 $ 700,000 $ 50,000 Convertible promissory notes – related party 3 $ n/a $ 88,850 |
Schedule of Changes in the Fair Value of Warrant Liabilities | The following tables present the changes in the fair value of warrant liabilities classified as Level 3 in the fair value hierarchy as June 30, 2024 and 2023: Private Fair value as of January 1, 2024 $ 700,000 Change in valuation inputs or other assumptions 300,000 Fair value as of March 31, 2024 $ 1,000,000 Change in valuation inputs or other assumptions (250,000 ) Fair value as of June 30, 2024 $ 750,000 Private Fair value as of January 1, 2023 $ 50,000 Change in valuation inputs or other assumptions 200,000 Fair value as of March 31, 2023 $ 250,000 Change in valuation inputs or other assumptions (100,000 ) Fair value as of June 30, 2023 $ 150,000 | The following tables present the changes in the fair value of warrant liabilities classified as Level 3 in the fair value hierarchy as of December 31, 2023 and 2022: Private Fair value as of January 1, 2023 $ 50,000 Change in valuation inputs or other assumptions 650,000 Fair value as of December 31, 2023 $ 700,000 Private Fair value as of January 1, 2022 $ 2,497,500 Change in valuation inputs or other assumptions (2,447,500 ) Fair value as of December 31, 2022 $ 50,000 |
Schedule of Changes in the Fair Value of the Level 3 Convertible Promissory Notes | The following tables present the changes in the fair value of the Level 3 convertible promissory notes: Fair value as of January 1, 2023 $ 88,850 Restatement of Convertible Promissory Note (88,850 ) Fair value as of December 31, 2023 $ — Fair value as of January 1, 2022 $ — Proceeds received through Convertible Promissory Note 900,000 Change in fair value (811,150 ) Fair value as of December 31, 2022 $ 88,850 | |
Warrant Liabilities [Member] | ||
Fair Value Measurements (Tables) [Line Items] | ||
Schedule of Key Inputs for the Binomial Lattice Model | The key inputs for the binomial lattice model as of June 30, 2024 and December 31, 2023 were as follows: Input As of As of Stock price $ 11.04 $ 10.58 Strike price $ 11.50 $ 11.50 Effective expiration date September 17, 2024 September 17, 2024 Volatility Immaterial Immaterial % Risk-free rate 4.90 % 4.34 % Dividend yield 0.0 % 0.0 % | The key inputs for the binomial lattice model as of December 31, 2023 and 2022 were as follows: Input As of As of Stock price $ 10.58 $ 10.02 Strike price $ 11.50 $ 11.50 Effective expiration date September 17, 2024 September 17, 2023 Volatility Immaterial 7.0 % Risk-free rate 4.34 % 4.69 % Dividend yield 0.0 % 0.0 % Input As of Stock price $ 10.02 Strike price $ 11.50 Expiration date of warrants September 17, 2023 Volatility 7.0 % Risk-free rate 4.69 % Dividend yield 0.0 % |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||||||||
Aug. 19, 2024 | Jul. 18, 2024 | Jun. 18, 2024 | May 18, 2024 | Apr. 18, 2024 | Feb. 28, 2024 | Feb. 02, 2024 | Jan. 18, 2024 | Dec. 12, 2023 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 16, 2023 | Mar. 15, 2023 | Mar. 15, 2023 | May 06, 2021 | Mar. 19, 2021 | Feb. 28, 2024 | Sep. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Proceeds IPO | $ 287,500,000 | |||||||||||||||||||||||
Transaction costs | $ 16,309,469 | |||||||||||||||||||||||
Cash underwriting fees | 5,750,000 | |||||||||||||||||||||||
Deferred underwriting fees | $ 10,062,500 | 10,062,500 | ||||||||||||||||||||||
Other offering costs | $ 496,969 | |||||||||||||||||||||||
Percentage of held in trust account | 80% | 80% | ||||||||||||||||||||||
Public share price per share (in Dollars per share) | $ 10 | $ 10 | ||||||||||||||||||||||
Aggregate of share sold, percentage | 15% | 15% | ||||||||||||||||||||||
Redemption of public shares percentage | 100% | 100% | ||||||||||||||||||||||
Interest to pay dissolution expenses | $ 100,000 | $ 100,000 | ||||||||||||||||||||||
Initial public offering price per Unit (in Dollars per share) | $ 10 | $ 10 | ||||||||||||||||||||||
Price per share (in Dollars per share) | $ 10 | $ 10 | ||||||||||||||||||||||
Aggregate redemption amount | $ 16,300,000 | $ 16,300,000 | ||||||||||||||||||||||
Trust account | 6,200,000 | |||||||||||||||||||||||
Extension payment amount | 648,046 | 578,694 | ||||||||||||||||||||||
Additional extension payment | $ 11,559 | $ 11,559 | $ 11,559 | $ 11,559 | ||||||||||||||||||||
Aggregate equity value | $ 250,000,000 | $ 250,000,000 | ||||||||||||||||||||||
Private placement (in Shares) | 2,734,433 | 2,734,433 | ||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 8 | |||||||||||||||||||||||
Aggregate investment amount | $ 27,344,330 | $ 27,344,330 | ||||||||||||||||||||||
Cash | $ 338,615 | 28,657 | $ 338,615 | 306,034 | 348,749 | $ 366,612 | ||||||||||||||||||
Working capital deficit | 6,959,912 | $ 6,063,520 | ||||||||||||||||||||||
Withdraw amount from trust account | 289,000,000 | |||||||||||||||||||||||
Transaction costs | 16,309,469 | |||||||||||||||||||||||
Cash underwriting fees | $ 500,000 | 5,750,000 | ||||||||||||||||||||||
Other offering costs | 496,969 | |||||||||||||||||||||||
General operating expenses | 157,474 | |||||||||||||||||||||||
Operating expenses | $ 335,127 | $ 76,974 | $ 335,127 | $ 76,974 | ||||||||||||||||||||
Trust account | $ 6,200,000 | |||||||||||||||||||||||
Aggregate shares (in Shares) | 763,144 | |||||||||||||||||||||||
Purchase amount | $ 2,400,000 | |||||||||||||||||||||||
Deposited and held in trust account and payable in cash | $ 500,000 | |||||||||||||||||||||||
Shares of common stock (in Shares) | 500,000 | |||||||||||||||||||||||
Post combination | $ 5,000,000 | |||||||||||||||||||||||
Deferred underwriting fee | $ 500,000 | |||||||||||||||||||||||
Franchise tax | 40,000 | |||||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Aggregate redemption amount | $ 270,769,687 | 270,769,687 | ||||||||||||||||||||||
Trust account | $ 21,467,825 | |||||||||||||||||||||||
PIPE [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Number of share issued (in Shares) | 2,287,464 | |||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 10 | $ 10 | ||||||||||||||||||||||
Aggregate investment amount | $ 22,874,640 | |||||||||||||||||||||||
Agreed to purchase (in Shares) | 523,144 | |||||||||||||||||||||||
VWAP [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 8 | |||||||||||||||||||||||
Sponsor [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Initial public offering (in Shares) | 1,437,500 | 1,437,500 | ||||||||||||||||||||||
Price per share (in Dollars per share) | $ 0.02 | $ 0.03 | $ 0.03 | |||||||||||||||||||||
Common stock adjusted price per share (in Dollars per share) | $ 12.5 | $ 12.5 | ||||||||||||||||||||||
Sponsor [Member] | PIPE [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Agreed to purchase (in Shares) | 240,000 | |||||||||||||||||||||||
Business Combination [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Post business combination, percentage | 50% | 50% | ||||||||||||||||||||||
Initial business combination | $ 20,000 | $ 105,000 | ||||||||||||||||||||||
Subsequent Event [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Number of share issued (in Shares) | 2,287,464 | |||||||||||||||||||||||
Additional extension payment | $ 11,559 | |||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 10 | $ 8 | $ 10 | |||||||||||||||||||||
Aggregate investment amount | $ 22,874,640 | |||||||||||||||||||||||
Trust Account [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Price per share (in Dollars per share) | $ 10 | $ 10 | ||||||||||||||||||||||
Class A Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 10 | $ 11.5 | $ 11.5 | |||||||||||||||||||||
Number of share issued (in Shares) | 656,499 | 656,499 | ||||||||||||||||||||||
Sale of warrants (in Shares) | 14,583,333 | |||||||||||||||||||||||
Price per share (in Dollars per share) | $ 10 | |||||||||||||||||||||||
Common stock outstanding (in Shares) | 1,522,544 | 1,522,544 | ||||||||||||||||||||||
Price per share (in Dollars per share) | $ 11 | $ 10.76 | $ 10.1 | |||||||||||||||||||||
Common stock outstanding (in Shares) | 9,147,981 | |||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 10 | $ 10 | ||||||||||||||||||||||
Aggregate investment amount | $ 6,564,990 | $ 6,564,990 | ||||||||||||||||||||||
Trust account | $ 21,467,825 | |||||||||||||||||||||||
Class A Common Stock [Member] | Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Common stock outstanding (in Shares) | 26,649,519 | 26,649,519 | ||||||||||||||||||||||
Price per share (in Dollars per share) | $ 10.16 | $ 10.16 | ||||||||||||||||||||||
Converted share (in Shares) | 7,047,500 | 7,047,500 | ||||||||||||||||||||||
Class A Common Stock [Member] | Second Extension [Member] | Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Price per share (in Dollars per share) | $ 10.71 | |||||||||||||||||||||||
Class B Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Converted share (in Shares) | 7,047,500 | 7,047,500 | ||||||||||||||||||||||
Common stock outstanding (in Shares) | 140,000 | |||||||||||||||||||||||
Class B Common Stock [Member] | Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Converted share (in Shares) | (7,047,500) | (7,047,500) | ||||||||||||||||||||||
Forecast [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Additional extension payment | $ 11,559 | |||||||||||||||||||||||
IPO [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 10 | |||||||||||||||||||||||
Proceeds IPO | $ 250,000,000 | |||||||||||||||||||||||
Number of share issued (in Shares) | 3,750,000 | |||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 10 | |||||||||||||||||||||||
IPO [Member] | Trust Account [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 10 | |||||||||||||||||||||||
IPO [Member] | Class A Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Initial public offering (in Shares) | 25,000,000 | 25,000,000 | 25,000,000 | |||||||||||||||||||||
Proceeds IPO | $ 250,000,000 | |||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 10 | |||||||||||||||||||||||
Additional Units [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 10 | |||||||||||||||||||||||
Proceeds IPO | $ 37,500,000 | |||||||||||||||||||||||
Number of share issued (in Shares) | 3,750,000 | |||||||||||||||||||||||
Private Placement [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 1.5 | $ 1.5 | ||||||||||||||||||||||
Sale of warrants (in Shares) | 500,000 | 4,500,000 | 4,500,000 | |||||||||||||||||||||
Proceeds from private placement | $ 6,750,000 | $ 6,750,000 | ||||||||||||||||||||||
Sponsor [Member] | Class A Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Converted share (in Shares) | 7,047,500 | |||||||||||||||||||||||
Sponsor [Member] | Class A Common Stock [Member] | Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Converted share (in Shares) | 7,047,500 | |||||||||||||||||||||||
Sponsor [Member] | Class B Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Converted share (in Shares) | 7,047,500 | |||||||||||||||||||||||
Sponsor [Member] | Class B Common Stock [Member] | Common Stock [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Converted share (in Shares) | 7,047,500 | |||||||||||||||||||||||
Common Stock [Member] | Class A Common Stock [Member] | Second Extension [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Price per share (in Dollars per share) | $ 10.71 | |||||||||||||||||||||||
Bolt Threads [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Per share price (in Dollars per share) | $ 10 | 10 | ||||||||||||||||||||||
Purchase Price [Member] | ||||||||||||||||||||||||
Description of Organization and Business Operations (Details) [Line Items] | ||||||||||||||||||||||||
Purchase price (in Dollars per share) | $ 10 | $ 10 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Summary of Significant Accounting Policies [Line Items] | ||||||
Offering costs (in Dollars) | $ 15,827,645 | |||||
Warrants offering cost (in Dollars) | $ (729,167) | $ (291,666) | $ 145,833 | $ 291,667 | $ 1,895,834 | $ (7,138,542) |
Effective tax rate | (80.17%) | 7.16% | ||||
Statutory tax rate | 21% | 21% | 21% | 21% | 21% | 21% |
Insured limit amount (in Dollars) | $ 250,000 | $ 250,000 | $ 250,000 | |||
Effective tax rate | (2.62%) | (6.87%) | 1.97% | (27.24%) | (80.20%) | 7.10% |
Warrant [Member] | ||||||
Summary of Significant Accounting Policies [Line Items] | ||||||
Warrants offering cost (in Dollars) | $ 481,824 | $ 481,824 | ||||
Class A common stock subject to possible redemption [Member] | ||||||
Summary of Significant Accounting Policies [Line Items] | ||||||
Shares subject to subject to possible redemption (in Shares) | 577,937 | 577,937 | 577,937 | 28,750,000 | ||
Class A Common Stock [Member] | ||||||
Summary of Significant Accounting Policies [Line Items] | ||||||
Shares subject to subject to possible redemption (in Shares) | 577,937 | 577,937 | 577,937 | 28,750,000 | ||
Purchase to share (in Shares) | 14,583,333 | |||||
Warrants exercisable (in Shares) | 14,583,333 | 14,583,333 | ||||
IPO [Member] | ||||||
Summary of Significant Accounting Policies [Line Items] | ||||||
Offering costs (in Dollars) | $ 15,827,645 | $ 15,827,645 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - Schedule of Class A Common Stock Reflected in the Consolidated Condensed Balance Sheet - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Class A Common Stock Reflected in the Consolidated Condensed Balance Sheet [Line Items] | ||||
Gross proceeds | $ 287,500,000 | |||
Less: | ||||
Proceeds allocated to Public Warrants | (9,195,833) | |||
Class A common stock issuance costs | (15,827,645) | |||
Plus: | ||||
Accretion of carrying value to redemption value | $ 85,456 | $ 43,863 | $ 2,942,345 | 27,881,248 |
Class A common stock subject to possible redemption | $ 6,357,464 | $ 6,272,008 | 6,228,145 | $ 290,357,770 |
Less: | ||||
Redemption | $ (287,071,970) |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Class A Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net (loss) income | $ 23,707 | $ 55,880 | $ (66,593) | $ 153,102 | $ (782,184) | |
Basic weighted average shares outstanding | 577,937 | 2,100,481 | 577,937 | 2,100,481 | 7,511,529 | |
Basic net (loss) income per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | |
Class A Non-Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net (loss) income | $ 289,084 | $ 187,488 | $ (812,055) | $ 769,071 | $ (583,482) | |
Basic weighted average shares outstanding | 7,047,500 | 7,047,500 | 7,047,500 | 10,551,265 | 5,603,340 | |
Basic net (loss) income per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | |
Class B [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net (loss) income | $ 5,743 | $ 3,724 | $ (16,132) | $ 216,786 | $ (164,960) | $ 1,969,342 |
Basic weighted average shares outstanding | 140,000 | 140,000 | 140,000 | 2,974,190 | 1,584,160 | 7,187,500 |
Basic net (loss) income per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | $ 0.27 |
Class A [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net (loss) income | $ 7,877,369 | |||||
Basic weighted average shares outstanding | 28,750,000 | |||||
Basic net (loss) income per common share | $ 0.27 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share (Parentheticals) - $ / shares | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Class A Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 577,937 | 2,100,481 | 577,937 | 2,100,481 | 7,511,529 | |
Diluted net (loss) income per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | |
Class A Non-Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 7,047,500 | 7,047,500 | 7,047,500 | 10,551,265 | 5,603,340 | |
Diluted net (loss) income per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | |
Class B [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 140,000 | 140,000 | 140,000 | 2,974,190 | 1,584,160 | 7,187,500 |
Diluted net (loss) income per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | $ 0.27 |
Class A [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 28,750,000 | |||||
Diluted net (loss) income per common share | $ 0.27 |
Public Offering (Details)
Public Offering (Details) - $ / shares | 6 Months Ended | 12 Months Ended | |||
May 06, 2021 | Mar. 19, 2021 | Jun. 30, 2024 | Dec. 31, 2023 | Feb. 02, 2024 | |
Public Offering [Line Items] | |||||
Purchase price, per unit | $ 8 | ||||
Class A Common Stock [Member] | |||||
Public Offering [Line Items] | |||||
Purchase price, per unit | $ 10 | $ 10 | |||
Per share price | $ 10 | $ 11.5 | $ 11.5 | ||
Sale of additional units (in Shares) | 656,499 | 656,499 | |||
Initial Public Offering [Member] | |||||
Public Offering [Line Items] | |||||
Purchase price, per unit | $ 10 | ||||
Per share price | $ 10 | ||||
Sale of additional units (in Shares) | 3,750,000 | ||||
Initial Public Offering [Member] | Class A Common Stock [Member] | |||||
Public Offering [Line Items] | |||||
Sale of units (in Shares) | 25,000,000 | 25,000,000 | 25,000,000 | ||
Purchase price, per unit | $ 10 | ||||
Additional Units [Member] | |||||
Public Offering [Line Items] | |||||
Per share price | $ 10 | ||||
Sale of additional units (in Shares) | 3,750,000 |
Private Placement (Details)
Private Placement (Details) - USD ($) | 6 Months Ended | 12 Months Ended | |
May 06, 2021 | Jun. 30, 2024 | Dec. 31, 2023 | |
Class A Common Stock [Member] | |||
Private Placement [Line Items] | |||
Purchased an aggregate of shares (in Shares) | 14,583,333 | ||
Exercise price per share | $ 11.5 | ||
Private Placement Warrants [Member] | |||
Private Placement [Line Items] | |||
Purchased an aggregate of shares (in Shares) | 500,000 | 4,500,000 | 4,500,000 |
Price per share | $ 1.5 | $ 1.5 | $ 1.5 |
Aggregate amount (in Dollars) | $ 6,750,000 | ||
Sale of an additional units (in Shares) | 500,000 | ||
Aggregate amount (in Dollars) | $ 6,750,000 | $ 6,750,000 | |
Over-Allotment Option [Member] | |||
Private Placement [Line Items] | |||
Aggregate amount (in Dollars) | $ 750,000 | ||
Aggregate amount (in Dollars) | $ 750,000 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 1 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||
Apr. 03, 2024 | Dec. 18, 2023 | Mar. 17, 2023 | Mar. 15, 2023 | Mar. 15, 2023 | Mar. 08, 2023 | Aug. 26, 2022 | Feb. 25, 2022 | Jan. 31, 2021 | Jan. 31, 2021 | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | May 06, 2021 | |
Related Party Transactions [Line Items] | ||||||||||||||
Sponsor paid | $ 25,000 | $ 25,000 | ||||||||||||
Unsecured promissory note | $ 104,029 | $ 567,130 | ||||||||||||
Deposited aggregate trust account | $ 80,911 | $ 11,559 | ||||||||||||
Outstanding amount | 567,130 | 567,130 | ||||||||||||
Exceed warrant (in Shares) | 1,000,000 | 1,000,000 | ||||||||||||
Aggregate outstanding amount | $ 1,484,326 | $ 88,850 | ||||||||||||
Trust account termination date | Sep. 19, 2024 | Aug. 19, 2024 | ||||||||||||
Exceed warrants (in Shares) | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | ||||||||||
Working capital loan outstanding balance | $ 510,000 | |||||||||||||
Sponsor [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Number of shares issued (in Shares) | 1,437,500 | 1,437,500 | ||||||||||||
Deposited aggregate trust account | $ 567,130 | $ 567,130 | ||||||||||||
Unsecured promissory amount | $ 510,000 | |||||||||||||
Related Party [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Outstanding balance | 648,041 | 578,689 | ||||||||||||
Convertible notes outstanding | 2,047,054 | 1,484,326 | $ 88,850 | |||||||||||
Founder Shares Member [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Shares subject to forfeiture (in Shares) | ||||||||||||||
Related Party Loans [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Amount of debt that may be converted into warrants | 1,500,000 | 1,500,000 | ||||||||||||
Promissory Note With Related Party [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Aggregate principal amount | $ 500,000 | |||||||||||||
Convertible Promissory Note With Related Party [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Aggregate principal amount | $ 750,000 | $ 400,000 | ||||||||||||
Sponsor [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Conversion price (in Dollars per share) | $ 1.5 | |||||||||||||
Related Party [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Convertible notes outstanding | $ 2,047,054 | $ 1,484,326 | ||||||||||||
Class B Common Stock [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Conversion of common stock redemption (in Shares) | 7,047,500 | 7,047,500 | ||||||||||||
Class B Common Stock [Member] | Founder Shares Member [Member] | Sponsor [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Number of shares issued (in Shares) | 7,187,500 | 7,187,500 | ||||||||||||
Shares subject to forfeiture (in Shares) | 937,500 | |||||||||||||
Issued and outstanding common stock percentage | 20% | 20% | ||||||||||||
Stock price trigger to transfer per share (in Dollars per share) | $ 12 | $ 12 | ||||||||||||
Forfeiture shares (in Shares) | 937,500 | |||||||||||||
Note Warrant [Member] | ||||||||||||||
Related Party Transactions [Line Items] | ||||||||||||||
Price of warrant (in Dollars per share) | $ 1.5 | $ 1.5 | $ 1.5 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
Nov. 01, 2024 | Feb. 02, 2024 | Aug. 16, 2022 | Aug. 16, 2022 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Commitments and Contingencies [Line Items] | |||||||||
U.S. federal excise tax, percentage | 1% | ||||||||
Fair market value, percentage | 1% | 1% | |||||||
Underwriting fee price per unit (in Dollars per share) | $ 0.35 | $ 0.35 | $ 0.35 | ||||||
Deferred underwriting commissions payable | $ 10,062,500 | $ 10,062,500 | $ 10,062,500 | ||||||
Economic interest (in Shares) | 100,000 | ||||||||
Founders shares (in Shares) | 100,000 | ||||||||
Consulting fees | $ 20,500 | ||||||||
Excise tax percentage | 1% | 1% | |||||||
Deposited and held in trust account and payable in cash | $ 500,000 | ||||||||
Price per share (in Dollars per share) | $ 8 | ||||||||
Payment for underwriting fees | $ 500,000 | $ 5,750,000 | |||||||
Consulting fees | $ 0 | $ 20,500 | $ 0 | $ 20,500 | |||||
Common Stock [Member] | Underwriting Agreement [Member] | |||||||||
Commitments and Contingencies [Line Items] | |||||||||
Number of shares issued (in Shares) | 500,000 | ||||||||
Number of value issued | $ 5,000,000 | ||||||||
Forecast [Member] | |||||||||
Commitments and Contingencies [Line Items] | |||||||||
Interest per annum | 10% | ||||||||
Underpayment penalty percentage | 5% | ||||||||
Liability unpaid percentage | 25% |
Stockholders_ Deficit (Details)
Stockholders’ Deficit (Details) - $ / shares | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Mar. 15, 2023 | Mar. 15, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | |
Stockholders Deficit [Line Items] | ||||||
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | 1,000,000 | |||
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||
Preferred stock, shares issued | ||||||
Preferred stock, shares outstanding | ||||||
Business Combination [Member] | ||||||
Stockholders Deficit [Line Items] | ||||||
Percentage of conversion basis | 20% | |||||
Convertible stock conversion ratio 1 | 20% | |||||
Class A Common Stock [Member] | ||||||
Stockholders Deficit [Line Items] | ||||||
Common stock, shares authorized | 200,000,000 | 200,000,000 | 200,000,000 | |||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||
Common stock, voting rights | one | one | ||||
Temporary equity, issued | 577,937 | 577,937 | 28,750,000 | |||
Temporary equity, outstanding | 577,937 | 577,937 | 28,750,000 | |||
Common stock, shares issued | 7,047,500 | 7,047,500 | ||||
Common stock, shares outstanding | 7,047,500 | 7,047,500 | ||||
Class B Common Stock [Member] | ||||||
Stockholders Deficit [Line Items] | ||||||
Common stock, shares authorized | 20,000,000 | 20,000,000 | 20,000,000 | |||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||
Common stock, voting rights | one | one | ||||
Conversion of common stock redemption | 7,047,500 | 7,047,500 | ||||
Common stock, shares issued | 140,000 | 140,000 | 7,187,500 | |||
Common stock, shares outstanding | 140,000 | 140,000 | 7,187,500 | |||
Common Stock [Member] | Class A Common Stock [Member] | ||||||
Stockholders Deficit [Line Items] | ||||||
Conversion of common stock redemption | 7,047,500 | 7,047,500 | ||||
Common Stock [Member] | Class B Common Stock [Member] | ||||||
Stockholders Deficit [Line Items] | ||||||
Conversion of common stock redemption | (7,047,500) | (7,047,500) |
Warrants (Details)
Warrants (Details) - $ / shares | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | |
Warrants [Line Items] | |||
Warrants outstanding (in Shares) | 9,583,333 | 9,583,333 | 9,583,333 |
Warrant expire | 5 years | 5 years | |
Price per share | $ 10 | $ 10 | |
Business Combination [Member] | |||
Warrants [Line Items] | |||
Business combination issue price per share | $ 9.2 | $ 9.2 | |
Total equity proceeds, percentage | 60% | 60% | |
Private Placement Warrants [Member] | |||
Warrants [Line Items] | |||
Warrants outstanding (in Shares) | 5,000,000 | 5,000,000 | |
Minimum [Member] | |||
Warrants [Line Items] | |||
Market value and newly issued price percentage | 100% | 100% | |
Redemption trigger price per share | $ 10 | ||
Stock price trigger for redemption of public warrants | $ 10 | ||
Maximum [Member] | |||
Warrants [Line Items] | |||
Market value and newly issued price percentage | 180% | 180% | |
Redemption trigger price per share | $ 18 | ||
Stock price trigger for redemption of public warrants | $ 18 | ||
Class A Common Stock [Member] | |||
Warrants [Line Items] | |||
Price per share | 10 | ||
Warrant price per shares | 0.1 | ||
Stock price trigger for redemption of public warrants | 10 | ||
Redemption price per public warrant | 0.1 | ||
Class A Common Stock [Member] | Business Combination [Member] | |||
Warrants [Line Items] | |||
Business combination issue price per share | 9.2 | ||
Class A Common Stock [Member] | Business Combination [Member] | |||
Warrants [Line Items] | |||
Business combination issue price per share | 9.2 | ||
Class A Common Stock [Member] | Private Placement Warrants [Member] | |||
Warrants [Line Items] | |||
Price per share | 18 | ||
Warrant price per shares | 0.01 | 0.01 | |
Warrant redemption condition minimum share price | 18 | ||
Redemption of Warrants [Member] | Class A Common Stock [Member] | |||
Warrants [Line Items] | |||
Price per share | $ 18 | $ 18 | |
Warrants [Member] | |||
Warrants [Line Items] | |||
Market value and newly issued price percentage | 115% | 115% | |
Warrants [Member] | Class A Common Stock [Member] | |||
Warrants [Line Items] | |||
Price per share | $ 10 | ||
Stock price trigger for redemption of public warrants | $ 10 | ||
Private Placement Warrants [Member] | |||
Warrants [Line Items] | |||
Warrants outstanding (in Shares) | 5,000,000 | 5,000,000 |
Income Tax (Details)
Income Tax (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Tax [Abstract] | ||
Net operating loss carryovers | $ 0 | $ 0 |
Valuation allowance | $ 425,978 | $ 201,748 |
Income Tax (Details) - Schedule
Income Tax (Details) - Schedule of Net Deferred Tax Assets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred tax assets | ||
Net operating loss carryforward | ||
Startup/Organization Expenses | 838,918 | 412,939 |
Total deferred tax assets | 838,918 | 412,939 |
Valuation allowance | (838,918) | (412,939) |
Deferred tax assets, net of allowance |
Income Tax (Details) - Schedu_2
Income Tax (Details) - Schedule of Income Tax Provision - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Federal | ||||||
Current | $ 653,044 | $ 759,647 | ||||
Deferred | (425,978) | (201,748) | ||||
State | ||||||
Current | ||||||
Deferred | ||||||
Change in valuation allowance | 425,978 | 201,748 | ||||
Income tax provision | $ 8,557 | $ 31,679 | $ 17,323 | $ 561,928 | $ 653,044 | $ 759,647 |
Income Tax (Details) - Schedu_3
Income Tax (Details) - Schedule of Reconciliation of the Federal Income Tax Rate | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Reconciliation of the Federal Income Tax Rate [Abstract] | ||||||
Statutory federal income tax rate | 21% | 21% | 21% | 21% | 21% | 21% |
State taxes, net of federal tax benefit | 0% | 0% | ||||
Change in fair value of warrants | (48.90%) | (14.10%) | ||||
Transaction costs associated with the Initial Public Offering | 0% | 0% | ||||
Change in fair value of convertible promissory note – related party | 0% | (1.70%) | ||||
Change in valuation allowance | (52.30%) | 1.90% | ||||
Income tax provision | (2.62%) | (6.87%) | 1.97% | (27.24%) | (80.20%) | 7.10% |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2024 | |
Fair Value Measurements [Abstract] | |||
Asset held in trust | $ 6,218,429 | $ 290,646,467 | $ 6,365,874 |
Redemption of payment for franchise tax and income tax | 288,183,427 | ||
Interest income | $ 871,000 | ||
Dividend | $ 0 |
Fair Value Measurements (Deta_2
Fair Value Measurements (Details) - Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 |
Level 1 [Member] | |||
Assets: | |||
Investments held in Trust Account | $ 6,218,429 | $ 290,646,467 | |
Related Party [Member] | Level 3 [Member] | |||
Liabilities: | |||
Convertible promissory notes – related party | 88,850 | ||
Public Warrants [Member] | Level 2 [Member] | |||
Liabilities: | |||
Warrant Liabilities | $ 1,437,500 | 1,341,667 | 95,833 |
Private Placement Warrants [Member] | Level 3 [Member] | |||
Liabilities: | |||
Warrant Liabilities | $ 750,000 | $ 700,000 | $ 50,000 |
Fair Value Measurements (Deta_3
Fair Value Measurements (Details) - Schedule of Key Inputs for the Binomial Lattice Model | 12 Months Ended | ||
Dec. 31, 2023 $ / shares $ / item | Dec. 31, 2022 $ / shares $ / item | Jun. 30, 2024 $ / shares | |
Schedule of Estimated Fair Value of the Convertible Promissory Notes [Line Items] | |||
Stock price (in Dollars per share) | $ 10 | $ 10 | |
Binomial Lattice Model [Member] | |||
Schedule of Estimated Fair Value of the Convertible Promissory Notes [Line Items] | |||
Stock price (in Dollars per share) | $ 10.58 | $ 10.02 | |
Strike price (in Dollars per Item) | $ / item | 11.5 | 11.5 | |
Effective expiration date | Sep. 17, 2024 | Sep. 17, 2023 | |
Volatility | 7% | ||
Risk-free rate | 4.34% | 4.69% | |
Dividend yield | 0% | 0% | |
Convertible Promissory Notes [Member] | |||
Schedule of Estimated Fair Value of the Convertible Promissory Notes [Line Items] | |||
Stock price (in Dollars per share) | $ 10.02 | ||
Strike price (in Dollars per Item) | $ / item | 11.5 | ||
Effective expiration date | Sep. 17, 2023 | ||
Volatility | 7% | ||
Risk-free rate | 4.69% | ||
Dividend yield | 0% |
Fair Value Measurements (Deta_4
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities - Private Placement [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) | 3 Months Ended | 12 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Fair value at beginning | $ 1,000,000 | $ 700,000 | $ 250,000 | $ 50,000 | $ 50,000 | $ 2,497,500 |
Change in valuation inputs or other assumptions | (250,000) | 300,000 | (100,000) | 200,000 | 650,000 | (2,447,500) |
Fair value at ending | $ 750,000 | $ 1,000,000 | $ 150,000 | $ 250,000 | $ 700,000 | $ 50,000 |
Fair Value Measurements (Deta_5
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of the Level 3 Convertible Promissory Notes - Fair Value, Inputs, Level 3 [Member] - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Changes in the Fair Value of the Level 3 Convertible Promissory Notes [Line Items] | ||
Fair value at beginning | $ 88,850 | |
Proceeds received through Convertible Promissory Note | 900,000 | |
Change in fair value | (811,150) | |
Restatement of Convertible Promissory Note (Note 2) | (88,850) | |
Fair value at ending | $ 88,850 |
Franchise and Income Tax With_2
Franchise and Income Tax Withdrawal (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
Apr. 09, 2024 | Apr. 03, 2024 | Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Franchise and Income Tax Withdrawal [Line Items] | |||||||||
Withdrew from trust account | $ 1,982,457 | ||||||||
Remitted tax authorities | 1,518,949 | ||||||||
Remitted to government authorities | 463,508 | ||||||||
Trust funds for payment | 157,474 | ||||||||
Operating expenses | $ 335,127 | $ 76,974 | $ 335,127 | $ 76,974 | |||||
Payment to income tax obligations | $ 464,342 | $ 448,349 | $ 448,349 | $ 511,000 | |||||
Subsequent Event [Member] | |||||||||
Franchise and Income Tax Withdrawal [Line Items] | |||||||||
Payment to income tax obligations | $ 11,000 | $ 453,342 | |||||||
Sponsor [Member] | Subsequent Event [Member] | |||||||||
Franchise and Income Tax Withdrawal [Line Items] | |||||||||
Aggregate principal amount | $ 510,000 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | Apr. 03, 2024 | Feb. 02, 2024 | Jan. 18, 2024 | Mar. 08, 2023 | Aug. 26, 2022 | Feb. 25, 2022 | Jul. 11, 2024 | Jun. 30, 2024 | Feb. 28, 2024 | Dec. 31, 2023 | Dec. 31, 2022 |
Subsequent Event [Line Items] | |||||||||||
Additional extension payment (in Dollars) | |||||||||||
Price per share (in Dollars per share) | $ 8 | ||||||||||
Warrants issued | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | |||||||
Subsequent Event [Member] | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Additional extension payment (in Dollars) | $ 11,559 | ||||||||||
Termination date | Mar. 19, 2024 | ||||||||||
Deposit (in Dollars) | $ 500,000 | ||||||||||
Shares, Issued | 500,000 | ||||||||||
Post-combination common stock (in Dollars) | $ 5,000,000 | ||||||||||
Price per share (in Dollars per share) | $ 8 | $ 10 | |||||||||
Unsecured promissory note (in Dollars) | $ 220,000 | ||||||||||
Conversion price (in Dollars per share) | $ 1.5 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies (Details) - Schedule of Class A Common Stock Reflected in the Unaudited Consolidated Balance Sheets - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Class A Common Stock Reflected in the Unaudited Consolidated Balance Sheets [Abstract] | ||||
Gross proceeds | $ 287,500,000 | |||
Less: | ||||
Proceeds allocated to Public Warrants | (9,195,833) | |||
Class A common stock issuance costs | (15,827,645) | |||
Plus: | ||||
Accretion of carrying value to redemption value | $ 85,456 | $ 43,863 | $ 2,942,345 | 27,881,248 |
Class A common stock subject to possible redemption | $ 6,357,464 | $ 6,272,008 | 6,228,145 | $ 290,357,770 |
Less: | ||||
Redemption | $ (287,071,970) |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Class A Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net income (loss) | $ 23,707 | $ 55,880 | $ (66,593) | $ 153,102 | $ (782,184) | |
Basic weighted average shares outstanding | 577,937 | 2,100,481 | 577,937 | 2,100,481 | 7,511,529 | |
Basic and net income (loss) per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | |
Class A Non-Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net income (loss) | $ 289,084 | $ 187,488 | $ (812,055) | $ 769,071 | $ (583,482) | |
Basic weighted average shares outstanding | 7,047,500 | 7,047,500 | 7,047,500 | 10,551,265 | 5,603,340 | |
Basic and net income (loss) per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | |
Class B [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Allocation of net income (loss) | $ 5,743 | $ 3,724 | $ (16,132) | $ 216,786 | $ (164,960) | $ 1,969,342 |
Basic weighted average shares outstanding | 140,000 | 140,000 | 140,000 | 2,974,190 | 1,584,160 | 7,187,500 |
Basic and net income (loss) per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.1) | $ 0.27 |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share (Parentheticals) - $ / shares | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Class A Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 577,937 | 2,100,481 | 577,937 | 2,100,481 | 7,511,529 | |
Diluted net income (loss) per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | |
Class A Non-Redeemable [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 7,047,500 | 7,047,500 | 7,047,500 | 10,551,265 | 5,603,340 | |
Diluted net income (loss) per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | |
Class B [Member] | ||||||
Schedule of Basic and Diluted Net (Loss) Income Per Common Share [Line Items] | ||||||
Diluted weighted average shares outstanding | 140,000 | 140,000 | 140,000 | 2,974,190 | 1,584,160 | 7,187,500 |
Diluted net income (loss) per common share | $ 0.04 | $ 0.03 | $ (0.12) | $ 0.07 | $ (0.10) | $ 0.27 |
Fair Value Measurements (Deta_6
Fair Value Measurements (Details) - Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2022 |
Public Warrants [Member] | Level 2 [Member] | |||
Liabilities: | |||
Warrant Liabilities | $ 1,437,500 | $ 1,341,667 | $ 95,833 |
Private Placement Warrants [Member] | Level 3 [Member] | |||
Liabilities: | |||
Warrant Liabilities | $ 750,000 | $ 700,000 | $ 50,000 |
Fair Value Measurements (Deta_7
Fair Value Measurements (Details) - Schedule of Key Inputs for the Binomial Lattice Model | Jun. 30, 2024 | Dec. 31, 2023 |
Stock Price [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Key inputs | 11.04 | 10.58 |
Strike Price [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Key inputs | 11.5 | 11.5 |
Effective expiration date [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Key inputs | September 17, 2024 | September 17, 2024 |
Volatility [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Key inputs | Immaterial | Immaterial% |
Risk-free rate [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Key inputs | 4.9 | 4.34 |
Dividend yield [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Key inputs | 0 | 0 |
Fair Value Measurements (Deta_8
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities - Private Placement [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) | 3 Months Ended | 12 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Changes in the Fair Value of Warrant Liabilities [Line Items] | ||||||
Fair value at beginning | $ 1,000,000 | $ 700,000 | $ 250,000 | $ 50,000 | $ 50,000 | $ 2,497,500 |
Change in valuation inputs or other assumptions | (250,000) | 300,000 | (100,000) | 200,000 | 650,000 | (2,447,500) |
Fair value at ending | $ 750,000 | $ 1,000,000 | $ 150,000 | $ 250,000 | $ 700,000 | $ 50,000 |